2008

Southern AIDS Living Quilt Raises Awareness at National HIV Summit: Women empower others by sharing personal stories of living with HIV/AIDS
PRNewswire - November 21, 2008
WASHINGTON, Nov. 21 /PRNewswire-USNewswire/ -- AIDS is the leading cause of death for African American women ages 25-34 today. HIV infections could be reduced by 30 percent per year if all HIV infected persons knew of their infection and adopted behavioral changes to limit the spread of the disease. The Southern AIDS L


Roche Holds Sixth Annual Children's Walk in Nutley
PRNewswire - November 21, 2008
-- More than 800 Employees Volunteer to Support Children Affected by HIV/AIDS in New Jersey and Africa NUTLEY, N.J., Nov. 21 /PRNewswire/ -- Today, more than 800 local Roche employees are participating in the Sixth Annual Roche Children s Walk to raise funds to support children infected and affected by HIV/AIDS in New


Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008
PRNewswire - November 20, 2008
-- Nearly 90 Percent of Patients Achieve Undetectable Viral Load in Phase IIa Trial Within 28 Days of Combined Treatment With Standard of Care CORK, Ireland , November 20/PRNewswire/ -- New clinical data demonstrate the safety and antiviral activity of TMC435, an investigational protease inhibitor (PI) being developed


Tibotec Begins Enrollment in Europe for Phase III Trial of Telaprevir in HCV Patients who Failed Prior Treatment
PRNewswire - November 20, 2008
-- Telaprevir Data Presented at AASLD CORK, Ireland , November 20/PRNewswire/ -- Tibotec BVBA today announced that it has begun enrolling patients in its phase III study of telaprevir (VX-950), an investigational protease inhibitor (PI), in patients with chronic genotype 1 hepatitis C virus (HCV) for whom the current s


Green Family Foundation Sponsors Alicia Keys' Keep a Child Alive College Student AIDS Summit
PRNewswire - November 20, 2008
-- Kimberly Green Joins KCA College in Welcoming 400 Student AIDS Activists and Partner Schools to Combat HIV/AIDS NEW YORK, Nov. 20 /PRNewswire/ -- On November 15th, Green Family Foundation (GFF) (www.greenff.org) president Kimberly Green joined Keep a Child Alive (KCA) Co-Founder and Global Ambassador Alicia Keys and


Faith and Civil Society Leaders Call for Truth and Leadership in U.S. HIV Prevention Efforts
PRNewswire - November 20, 2008
WASHINGTON, Nov. 20 /PRNewswire-USNewswire/ -- The following is being released by Center for Health & Gender Equity: WHAT: World AIDS Day Audio Media Conference WHEN: Tuesday, November 25, 2008 -- 11:00 a.m. EST Call-in number: 1-800-949-8476 RSVP strongly encouraged: https://cc.readytalk.com/r/1xe41i2yre8rs WH


Miami Physicians Sentenced to Prison for Their Roles in a $6.8 Million Medicare Fraud Scheme
PRNewswire - November 20, 2008
WASHINGTON, Nov. 20 /PRNewswire-USNewswire/ -- Miami physicians Carlos Contreras, 61, and Ramon Pichardo, 58, were sentenced today to 37 months and 48 months in prison, respectively, for defrauding the Medicare program in connection with a $6.8 million HIV infusion fraud scheme, Acting Assistant Attorney General Matthe


NO/AIDS Task Force Awarded Internship in Leadership Development by R. Scott Hitt Foundation: 2009 Application Process Opens December 1st
PRNewswire - November 18, 2008
NEW ORLEANS, Nov. 18 /PRNewswire-USNewswire/ -- This month, the world watched history happen as the United States elected it s first African-American president. Overshadowed by that, but no less historical, was that over 111 openly gay, lesbian, bisexual and transgender candidates were on ballots across the country and


Miami HIV Clinic Administrator and Two Miami Residents Sentenced for Their Roles in a $14 Million Medicare Fraud Scheme
PRNewswire - November 18, 2008
WASHINGTON, Nov. 18 /PRNewswire-USNewswire/ -- Miami residents Dilcia Marinez, Juan Carlos Castaneda and Luis Frias each were sentenced to prison today for their roles in defrauding the Medicare program and laundering the illegal proceeds in connection with a $14 million HIV infusion fraud scheme, Acting Assistant Atto


Long-Term TITAN Study Evaluates PREZISTA(R)/ritonavir vs. lopinavir/ritonavir as Part of HIV Combination Therapy in Treatment-Experienced Adults
PRNewswire - November 18, 2008
BRIDGEWATER, N.J., Nov. 18 /PRNewswire/ -- Tibotec recently announced long-term study results from a phase 3 clinical trial, which compared PREZISTA(R) (darunavir)/ ritonavir to lopinavir /ritonavir, as part of HIV combination therapy, in lopinavir/r-naive, treatment-experienced HIV-1 infected adults.


Record Number of Youth Dancing Worldwide to Take a Stand Against HIV and AIDS
PRNewswire - November 17, 2008
-- Archbishop Desmond Tutu Kicks off Live Connection AMSTERDAM, November 17/PRNewswire/ -- More than 50.000 young people will take a stand on the 29th of November during Dance4Life events in 19 countries. The worldwide Dance4Life movement is growing rapidly. This year 150,000 extra youth were reached with Dance4Life Sc


GLEH LA, a Nonprofit Affiliate of Gay & Lesbian Elder Housing, Announces New Program Director
PRNewswire - November 13, 2008
LOS ANGELES, Nov. 13 /PRNewswire/ -- Gay & Lesbian Elder Housing- Los Angeles (GLEH LA) and the managing general partner of the nation s first nonprofit, affordable, multicultural housing development that includes a community service center supporting the needs of GLBT elders, for both residents and non-residents,


Gilead to Topple GSK as the Top Player in the Anti-Infectives Drug Market in 2014: Stringent, Yet Ill-Defined, Approval Standards Make it Difficult for Companies to Bring Hospital Antibiotics to Market, According to a New Report from Decision Resources
PRNewswire - November 12, 2008
WALTHAM, Mass., Nov. 12 /PRNewswire/ -- Decision Resources, one of the world s leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that Gilead will topple GlaxoSmithKline (GSK) as the top player in the anti-infectives drug market in 2014. According to the new report entitled Comm


Miami Clinic Owner Sentenced to 30 Months in Prison for $10.9 Million Medicare Fraud
PRNewswire - November 12, 2008
WASHINGTON, Nov. 12 /PRNewswire-USNewswire/ -- Miami clinic owner Nayda Freire, 61, was sentenced today to 30 months in prison for defrauding the Medicare program in connection with a $10.9 million HIV infusion fraud scheme, Acting Assistant Attorney General Matthew Friedrich of the Criminal Division and U.S. Attorney


Kenneth Cole Releases New Book 'AWEARNESS: Inspiring Stories About How To Make a Difference': Commemorates 25th Anniversary by launching initiative to encourage acts of service, volunteerism and social change
PRNewswire - November 12, 2008
NEW YORK, Nov. 12 /PRNewswire-FirstCall/ -- Designer and activist Kenneth Cole today released a book that celebrates the heritage of Kenneth Cole Productions, marrying his long term social mission with his new AWEARNESS initiative for empowering, encouraging and supporting acts of service, volunteerism and social chang


Tibotec Data Presented at ICAAC and HIV9 Follow key Regulatory Approvals for Anti-HIV Compounds
PRNewswire - November 12, 2008
-- New Findings From ARTEMIS and TITAN Studies Demonstrate Growth of the Tibotec Virology Franchise GLASGOW, Scotland, November 12/PRNewswire/ -- New data on PREZISTA(R) (darunavir), a protease inhibitor from Tibotec, will be presented at the Ninth International Congress on Drug Therapy in HIV Infection (HIV9) in Glasg


MANHUNT Leads Fight Against Spread of Sexually Transmitted Infections with Launch of MANHUNT Cares; Hires Senior Public Health Strategist from CDC
PRNewswire - November 11, 2008
CAMBRIDGE, Mass., Nov. 11 /PRNewswire/ -- Ken Herron, Chief Marketing Executive at Online Buddies Inc., the parent company of MANHUNT, announced today that David S. Novak of the Centers for Disease Control and Prevention (CDC) will join the team at Online Buddies, Inc. as the site s first Senior Public Health Strategis


GeoVax Labs, Inc. Announces Third Quarter 2008 Financial Results and Provides Operational Update
PRNewswire - November 10, 2008
ATLANTA, Nov. 10 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (BULLETIN BOARD: GOVX) ( GeoVax or the Company ), a biopharmaceutical firm developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced its third quarter 2008 financial results and provided


MTV's Staying Alive Marks Ten Years of Empowering Young People in Their Fight against HIV and AIDS
PRNewswire - November 10, 2008
-- MTV GLOBALLY PREMIERES ORIGINAL HIV/AIDS PROGRAMMING ON WORLD AIDS DAY -- HOUR LONG SPECIAL: THE DIARY OF KELLY ROWLAND It s about education. It s about empowerment. It s about opening dialogue. LIVERPOOL, N.Y., Nov. 10 /PRNewswire-FirstCall/ -- To mark 10 years of dedication and commitment in the fight against HIV/


World Vision Urges Obama Administration and New Congress to Make Poverty Alleviation a Top Foreign Policy Priority: U.S. leadership in global financial crisis must include focus on the world's poor
PRNewswire - November 10, 2008
-- Extreme poverty one of greatest terrors facing our world today, World Vision warns WASHINGTON, Nov. 10 /PRNewswire-USNewswire/ -- World Vision, a leading international humanitarian aid agency, congratulates President-elect Barack Obama on his win as the 44th President of the United States , and urges his leadersh


Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C
PRNewswire - November 10, 2008
PRINCETON, N.J., Nov. 10 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (NASDAQ:VRUS) , Roche and InterMune, Inc. (NASDAQ:ITMN) today announced that the first patients have been dosed in an innovative clinical trial in patients chronically infected with the hepatitis C virus (HCV). The trial (run in centers in


'Project Runway' Designer Brings Living Positive By Design Campaign to New York to Educate About Living With HIV and Combat Stigma Associated With the Disease
PRNewswire - November 7, 2008
-- Jack Mackenroth to debut signature campaign scarf at Gay Men s Health Crisis Fashion Forward fundraiser event NEW YORK, Nov. 7 /PRNewswire/ -- Jack Mackenroth, from the hit reality television series Project Runway, is nationally debuting an HIV and AIDS education campaign called Living Positive By Design, in New Yor


Obama Could Inherit Weaker Global Health Fund
PRNewswire - November 7, 2008
WASHINGTON, Nov. 7 /PRNewswire-USNewswire/ -- As the clock runs out on the Bush Administration, key US officials are working overtime to undermine a crucial international health program, the Global Fund to Fight AIDS, Tb and Malaria. US officials are attending a meeting of the Fund s Board in India , where


Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting
PRNewswire - November 7, 2008
PHILADELPHIA, Nov. 7 /PRNewswire/ -- Data from an investigational, open-label, randomized study assessing extended dosing regimens of PROCRIT(R) (Epoetin alfa) in treating anemia in subjects with Stages 3 - 4 chronic kidney disease (CKD) were presented today at the American Society of Nephrology 41st Annual Meeting.


50,000 Young People Dance to Celebrate Achievements in Pushing Back HIV and AIDS
PRNewswire - November 7, 2008
AMSTERDAM, November 7/PRNewswire/ -- Archbishop Desmond Tutu, Kofi Annan and Nafis Sadik Support Global Initiative Dance4Life On the 29th of November, fifty thousand young people will make a worldwide statement against HIV and AIDS. Connected live via satellite, young people in 19 countries will dance in unity and soli


Bavarian Nordic Reports Successful Safety Data From Phase II Study With IMVAMUNE(R)
PRNewswire - November 6, 2008
KVISTGARD, Denmark , November 6/PRNewswire-FirstCall/ -- Bavarian Nordic has completed a clinical safety report from a large Phase II study with IMVAMUNE(R) in HIV infected subjects that confirms the excellent safety profile of IMVAMUNE(R). Within the next few days the safety report of this study will be submitted to t


The Female Health Company Confirms Guidance for FY Ended September 30, 2008
PRNewswire - November 6, 2008
CHICAGO, Nov. 6 /PRNewswire-FirstCall/ -- The Female Health Company (AMEX:FHC) which manufactures and markets the FC and FC2 Female Condoms(R), today confirmed its guidance for the fiscal year ended September 30, 2008. We are very pleased to confirm that our August 2008 guidance regarding fiscal year 2008 growth in uni


Global AIDS Alliance Welcomes Election of Barack Obama
PRNewswire - November 5, 2008
WASHINGTON, Nov. 5 /PRNewswire-USNewswire/ -- The Global AIDS Alliance today welcomed the election of Senator Barack Obama as President of the United States . We look forward to working with President-elect Obama as he confronts that challenge of HIV/AIDS, which every day kills over 5,000 people and infects another 7,5


Stars to 'Tell It Like It Is' at MTV's European Music Awards: MTV and SpinVox team up to talk sex secrets, one night stands and condoms
PRNewswire - November 5, 2008
LONDON and NEW YORK, Nov. 5 /PRNewswire/ -- MTV S Staying Alive Foundation and SpinVox have teamed up with Lapeno, Mervin and Ed the notorious puppet from MTV s Fur TV show to promote sexual health amongst young people. The Telling It Like It Is campaign is a groundbreaking initiative that encourages young people to sp


Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at The AASLD Liver Meeting 2008
PRNewswire - November 3, 2008
-- Nearly 90 percent of patients achieve undetectable viral load in Phase IIa trial within 28 days of combined treatment with standard of care SAN FRANCISCO, Nov. 3 /PRNewswire/ -- New clinical data show antiviral activity of TMC435, an investigational protease inhibitor (PI) being developed by Tibotec BVBA for the tre


New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients
PRNewswire - November 1, 2008
-- Higher Sustained Virological Response Rates Recognized as Marker of Treatment Success SAN FRANCISCO, Calif., Nov. 1 /PRNewswire/ -- A new, independently-conducted study being presented at the 59th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) shows that PEGASYS(R) (peginterferon


Cheap Condoms for a Safer Sex Industry
PRNewswire - October 31, 2008
-- Safe4now Foundation Allows Prostitutes to Prevent AIDS or STD Infection AMSTERDAM, The Netherlands , October 31/PRNewswire/ -- Though condom prices are decreasing rapidly all over the world, prostitutes and other women working in the sex industry still have to pay enormous costs to guarantee a safe working environme


Roche Receives FDA Approval for Hepatitis C Viral Load Test on Its Fully Automated Real-Time PCR Platform: Improved laboratory efficiencies and standardization to personalize patient care
PRNewswire - October 30, 2008
PLEASANTON, Calif., Oct. 30 /PRNewswire/ -- Roche Molecular Diagnostics today announced that the U.S. Food & Drug Administration ( FDA ) has approved the COBAS(R) AmpliPrep / COBAS(R) TaqMan(R) HCV Test for use in the United States . The test uses Roche s proprietary real-time PCR technology to quantify the amount


Southern AIDS Living Quilt Raises Awareness on the Web: Women across the South share personal stories of living with HIV/AIDS
PRNewswire - October 30, 2008
MIAMI, Oct. 30 /PRNewswire-USNewswire/ -- AIDS is the leading cause of death for African American women ages 25-34 today. HIV infections could be reduced by 30 percent per year if all HIV infected persons knew of their infection and adopted behavioral changes to limit the spread of the disease. The Southern AIDS Living


New Report Finds Rising Risk of Infectious Diseases in America
PRNewswire - October 29, 2008
WASHINGTON, Oct. 29 /PRNewswire-USNewswire/ -- Trust for America s Health (TFAH) released a new report today, Germs Go Global: Why Emerging Infectious Diseases Are a Threat to America; which finds that at least 170,000 Americans die annually from newly emerging and re-emerging infectious diseases, a number that could i


Merck Serono's US Affiliate EMD Serono, Inc. and Theratechnologies Announce Collaboration and Licensing Agreement for Tesamorelin in the United States
PRNewswire - October 29, 2008
-- Merck Serono s US Affiliate EMD Serono, Inc. to Acquire Rights in Tesamorelin, a Phase 3 Compound Being Investigated for the Treatment of Excess Abdominal Fat in HIV Patients With Lipodystrophy in the US GENEVA, Switzerland , October 29/PRNewswire/ -- Merck KGaA, Darmstadt, Germany


House Candidates Jim Himes and Chris Shays Pledge Action on HIV/AIDS Epidemic
PRNewswire - October 29, 2008
NEW HAVEN, Conn., Oct. 29 /PRNewswire-USNewswire/ -- Both Jim Himes and Rep. Chris Shays, candidates for US House of Representatives from Connecticut s 4th district, have signed a pledge to support a comprehensive strategy to fight HIV/AIDS in the US and around the world. 14,899 residents of Connecticut are HIV-positiv


Senator Dean Barkley Pledges Action on HIV/AIDS Epidemic
PRNewswire - October 28, 2008
ST. PAUL, Minn., Oct. 28 /PRNewswire-USNewswire/ -- Dean Barkley, candidate for US Senate from Minnesota, has signed a pledge to support a comprehensive strategy to fight HIV/AIDS in the US and around the world. We hope that Al Franken, Norm Coleman and other candidates from Minnesota will also agree to sign the pledge


Sangamo BioSciences Presents Data at ICAAC Demonstrating 'In Vivo' Protection Against HIV Infection by CCR5-ZFN Therapeutic
PRNewswire - October 28, 2008
-- Preclinical Animal Data Demonstrates Selective Survival Advantage of ZFN-Treated Immune Cells after HIV Infection and Reduced Viral Loads WASHINGTON and RICHMOND, Calif., Oct. 28 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (NASDAQ:SGMO) announced today the presentation of data demonstrating that human CD4 T-


Bayer and Onyx Launch Educational Program to Raise Awareness About Liver Cancer and Its Risk Factors: New Survey Quantifies Misperceptions about Liver Cancer in the United States
PRNewswire - October 28, 2008
WAYNE, N.J. and EMERYVILLE, Calif., Oct. 28 /PRNewswire-FirstCall/ -- A new survey of more than 1,000 American adults revealed that general knowledge regarding liver cancer risk factors and treatment options is limited, even among individuals with a connection to the disease. According to the GfK Roper survey, among th


Why Are Some Veterans Who Are Coinfected With Hepatitis C and HIV More Likely to Be Treated for HCV Than Others?
PRNewswire - October 28, 2008
-- Research to be presented Sunday, November 2, 2008 at this year s liver meeting in San Francisco, California, October 31 - November 4 SAN FRANCISCO, Oct. 28 /PRNewswire/ -- Researchers from the Michael E. DeBakey VA Medical Center, led by Jennifer Kramer, Ph.D., looked at a population of U.S. veterans to determine th


Town Hall Meeting on Inequities in Clinical Trials Documents Ongoing 'Tuskegee Effect' When Recruiting Minorities for Research Studies: Health Officials/Patient Advocates Link Underrepresentation of Minorities in Clinical Trials with Higher Death Rates
PRNewswire - October 28, 2008
HOUSTON, Oct. 28 /PRNewswire-USNewswire/ -- What is keeping so many Americans and especially racial and ethnic minorities from taking part in medical studies for diseases from asthma to cancer? According to more than 100 political leaders, public health officials and patient advocates meeting in Harlem to address the u


Local Organization Receives Multi-Million Dollar Grants for Natural Family Planning, HIV Testing and Family Planning Services for Men
PRNewswire - October 28, 2008
PHILADELPHIA, Oct. 28 /PRNewswire-USNewswire/ -- The Family Planning Council was recently awarded three grants from the U.S. Department of Health & Human Services for a total of $3 million. These grants will support state-of-the-art research in three important health care areas: the use of Natural Family Planning a


Monogram Announces 2008 Third Quarter Financial Results
PRNewswire - October 27, 2008
-- Conference call today at 4:30 p.m. ET - SOUTH SAN FRANCISCO, Calif., Oct. 27 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. (NASDAQ:MGRM) today reported financial results for the quarter ended September 30, 2008. The Company had revenues of $16.1 million for the third quarter of 2008, 55% higher than $10.4 mil


Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients
PRNewswire - October 26, 2008
-- Data Analysis of Up to Four Years of Treatment Presented at ICAAC/IDSA 2008 Annual Meeting WASHINGTON, Oct. 26 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE:SGP) today reported a data analysis showing that vicriviroc, its investigational CCR5 receptor antagonist, demonstrated sustained viral suppressio


Data Reported at ICAAC Indicates Selzentry(TM) Phase III Treatment-Naive Trial Shows Increased Efficacy When Used With Enhanced Trofile(TM) Assay
PRNewswire - October 26, 2008
SOUTH SAN FRANCISCO, Calif., Oct. 26 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. (NASDAQ:MGRM) announced today that data presented this week demonstrated that in Pfizer Inc s (NYSE:PFE) phase III trial of Selzentry(TM) (maraviroc) in treatment naive individuals with CCR5-tropic HIV-1, increased efficacy was sh


Sequoia Pharmaceuticals Presents In Vitro and First-in-Human Data Supporting Further Development of SPI-256, a Novel Investigational Protease Inhibitor
PRNewswire - October 26, 2008
WASHINGTON, Oct. 26 /PRNewswire/ -- Sequoia Pharmaceuticals presented positive results today from two studies on SPI-256, a novel investigational HIV protease inhibitor (PI). One study based on an in vitro analysis demonstrates that the mode of interaction of SPI-256 with HIV protease provides a rationale for its high


Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults: Ninety-six week ARTEMIS data presented at ICAAC
PRNewswire - October 26, 2008
BRIDGEWATER, N.J., Oct. 26 /PRNewswire/ -- Ninety-six week results presented today from a phase 3, randomized, open-label, ongoing clinical trial showed that 79 percent of treatment-naive HIV-1 infected adults taking PREZISTA(R) 800 mg (two 400 mg tablets) with 100 mg ritonavir (r) once daily reached an und


Land O'Lakes Collaborates With Ethiopian Farmers to Create Livelihoods for People Living With HIV/AIDS
PRNewswire - October 24, 2008
ARDEN HILLS, Minn., Oct. 24 /PRNewswire/ -- The global fight against HIV/AIDS has received a boost from a partnership between Ethiopian dairy farmers and Land O Lakes, Inc., supported by funding from the President s Emergency Program for HIV/AIDS Relief (PEPFAR). Working together, the Land O Lakes International Develop


Innovative Sperm Bank Offers Donor Video and Pictures: Fertility Cryobank is First in the World to Offer Video and Pictures of Sperm Donors
PRNewswire - October 22, 2008
LOS ANGELES, Oct. 22 /PRNewswire/ -- Gail Taylor, President, today announced the launch of Fertility Cryobank, the world s first sperm bank to offer donor video interviews. Fertility Cryobank is one of the few sperm banks in the country to provide recent photos and a comprehensive genetic evaluation for each donor. It


U.S. Food and Drug Administration (FDA) Approves PREZISTA(R) Once-Daily as Part of Combination Therapy for Treatment-Naive Adults with HIV-1: PREZISTA also granted traditional approval
PRNewswire - October 22, 2008
BRIDGEWATER, N.J., Oct. 22 /PRNewswire/ -- The FDA has granted PREZISTA (darunavir) tablets, a protease inhibitor, approval for an expanded indication for once-daily dosing as part of HIV combination therapy in treatment-naive adults (those who have never taken HIV medication before). The FDA also granted traditional (


Southern AIDS Living Quilt Raises Awareness on the Web: Women across the South share personal stories of living with HIV/AIDS
PRNewswire - October 22, 2008
NEW ORLEANS, Oct. 22 /PRNewswire-USNewswire/ -- AIDS is the leading cause of death for African American women ages 25-34 today. HIV infections could be reduced by 30 percent per year if all HIV infected persons knew of their infection and adopted behavioral changes to limit the spread of the disease. The Southern AIDS


Gates Foundation Invests in 104 Novel Ideas for Global Health: Scientists from Diverse Set of Disciplines and Regions Receive $100,000 Each to Explore Bold, Untested Projects
PRNewswire - October 22, 2008
BANGKOK, Thailand , Oct. 22 /PRNewswire/ -- The Bill & Melinda Gates Foundation today announced 104 grants to explore bold and largely unproven ways to improve global health. The grants of US$100,000 each will be made to scientists from 22 countries and five continents. They mark the first round of funding from Gra


Class Action Jury Verdict Confirmed and Judgment Entered in Excess of $1.5 Million for Breach of Fiduciary Duties
PRNewswire - October 22, 2008
ENGLEWOOD, Colo., Oct. 22 /PRNewswire/ -- The Arapahoe County District Court confirmed a jury verdict and entered final judgment for more than $1.5 million in both compensatory and punitive damages, jointly and severally against a Fort Collins-based private company, PR Pharmaceuticals ( PRP ) and its President, Steven


Faith-Based Organizations From All Continents Create Global Network to Fight Maternal Death, AIDS, Poverty
PRNewswire - October 21, 2008
ISTANBUL, Turkey , Oct. 21 /PRNewswire-USNewswire/ -- More than 75 religious leaders and representatives of Hindu, Buddhist, Sikh, Jewish, Christian and Muslim faith-based organizations today formed a Global Interfaith Network to strengthen cooperation against the global urgencies of maternal death, AIDS and poverty.


GeoVax's DNA and MVA Vaccines Shipped to HIV Vaccine Trials Network for Use in the Upcoming Phase 2a Trial
PRNewswire - October 20, 2008
ATLANTA, Oct. 20 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (BULLETIN BOARD: GOVX) , an Atlanta based biotechnology company, developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, announced today it has shipped both DNA and MVA components of its AIDS vaccine


GeoVax Presents Data at AIDS Vaccine 2008 Conference
PRNewswire - October 16, 2008
ATLANTA, Oct. 16 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (BULLETIN BOARD: GOVX) , an Atlanta based, publicly traded biopharmaceutical company specializing in the prevention and treatment of infectious diseases, presented data on their AIDS vaccine (trial HVTN 065) at the AIDS Vaccine 2008 conference, on October 15


Southern AIDS Living Quilt Project Launch to Break Down Barriers: Web-based project educates and empowers through personal stories of Louisiana women and others across the South
PRNewswire - October 16, 2008
NEW ORLEANS, Oct. 16 /PRNewswire-USNewswire/ -- Seventy percent of people living with AIDS in Louisiana are minorities, with AIDS being the leading cause of death for African American women ages 25-34 today. On Wednesday, October 22, The Southern AIDS Coalition (SAC) and Test for Life will launch the Southern AIDS Livi


Statement of Admiral Joxel Garcia, Assistant Secretary for Health on National Latino AIDS Awareness Day, October 15, 2008
PRNewswire - October 15, 2008
WASHINGTON, Oct. 15 /PRNewswire-USNewswire/ -- Today is National Latino AIDS Awareness Day (NLAAD), which is designed to increase awareness of the devastating and disproportionate effects of HIV/AIDS in the Latino community. NLAAD also encourages HIV testing and supports connecting those living with HIV to care and tre


Tibotec Begins Enrollment for Phase III Study of Telaprevir, an Investigational Agent, in HCV Patients Who Failed Prior Treatment
PRNewswire - October 15, 2008
-- REALIZE is the first phase III study to evaluate a specifically targeted antiviral therapy for hepatitis C (STAT-C) across a full range of HCV-patients who failed prior treatment to current standard of care, including null responders MECHELEN, Belgium , Oct. 15 /PRNewswire-USNewswire/ -- Tibotec BVBA announced today


Children with Life-Threatening Illnesses Receive Hospice Care: HIV Positive Orphaned Muppet Cheers Soweto Hospice Pediatric Patients
PRNewswire - October 15, 2008
WASHINGTON, Oct. 15 /PRNewswire-USNewswire/ -- With support from the U.S. Agency for International Development (USAID) and funding from the U.S. President s Emergency Plan for AIDS Relief (PEPFAR) and other groups, Soweto Hospice has developed one of South Africa s first children s units to provide specialty care and r


Florida Congressional Candidate Annette Taddeo Pledges Action on HIV/AIDS Epidemic
PRNewswire - October 15, 2008
MIAMI, Oct. 15 /PRNewswire-USNewswire/ -- Annette Taddeo, candidate for US House of Representatives in Florida s 18th district, has pledged to support a comprehensive strategy to fight HIV/AIDS in the US and around the world. She joins Rep. Lincoln Diaz-Balart (R-FL), and twelve other candidates for the US House of Rep


Qorvis Congratulates YouthAIDS on Raising $1.2 Million+ at Gala: Star-Studded Event Marks Fourth Year of Qorvis/YouthAIDS Collaboration
PRNewswire - October 15, 2008
WASHINGTON, Oct. 15 /PRNewswire-USNewswire/ -- Washington, Hollywood and music elite were on hand Friday night at The Ritz-Carlton, Tysons Corner, Virginia for the 2008 Power of Music YouthAIDS Gala. Global Ambassador Ashley Judd hosted the star-studded affair, which raised more than $1.2 million in the fight against t


'Project Runway' Fashion Designer Brings Living Positive By Design Campaign to Atlanta to Educate About Living with HIV and Combat Stigma Associated with the Disease
PRNewswire - October 15, 2008
-- Jack Mackenroth to kick off AIDS Walk Atlanta weekend with local educational event ATLANTA, Oct. 15 /PRNewswire/ -- Jack Mackenroth, from the hit reality television series Project Runway, is coming to Atlanta to speak about a national HIV and AIDS education campaign called Living Positive By Design that he is involv


USAID Awards Grants for Development of New Tuberculosis Drugs, Diagnostics, and Management Approaches
PRNewswire - October 14, 2008
WASHINGTON, Oct. 14 /PRNewswire-USNewswire/ -- The U.S. Agency for International Development (USAID) is pleased to announce new grants to The Global Alliance for TB Drug Development and the International Union Against TB and Lung Disease. These grants will support late stage clinical trials for new drugs, diagnostics,


The Latino Commission on AIDS Call on Presidential Candidates to Honor National Latino AIDS Awareness Day on October 15
PRNewswire - October 14, 2008
NEW YORK, Oct. 14 /PRNewswire-USNewswire/ -- On the eve of the last Presidential debate, the Latino Commission on AIDS issued a Call for Endorsement of National Latino AIDS Awareness Day (NLAAD) to Senators John McCain and Barack Obama. We need the commitment of the future President of the United States to bring H


NBA Star's Daughter is Giving Back by Bringing Joy to Teens: Seattle Teens Gets Unexpected Surprise From Local Teen Star
PRNewswire - October 14, 2008
SEATTLE, Oct. 14 /PRNewswire/ -- Chantel Chani Christie, daughter of NBA Power couple Doug and Jackie Christie, gives back to her native state teens. Starting October 14, 2008 Chani plans to visit 20 local middle and high schools to bring joy to teens during this economic crisis. In conjunction with her morale booster


Nearly Half of Newly Diagnosed HIV/AIDS Cases in Los Angeles County Are Among Latinos: National Latino AIDS Awareness Day Encourages Latinos to Get Tested
PRNewswire - October 13, 2008
LOS ANGELES, Oct. 13 /PRNewswire/ -- WHAT -- Latinos make up almost half of all newly diagnosed HIV/AIDS cases reported in Los Angeles County compared to 19 percent nationally. -- A week of activities aimed at raising awareness and encouraging HIV counseling and testing to coincide with National Latino AIDS Awareness D


Peregrine Pharmaceuticals' anti-PS Technology Platform to Be Discussed at AIDS Vaccine 2008 Conference
PRNewswire - October 13, 2008
CAPE TOWN, South Africa and TUSTIN, Calif., Oct. 13 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) a clinical stage biopharmaceutical company developing monoclonal antibodies for cancer and serious viral infections, today reported the company s anti-phosphatidylserine (anti-PS) technology platf


Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests
PRNewswire - October 13, 2008
-- FirstVue(TM) HBSAG Test Found to Have Higher Sensitivity and Specificity than Other Rapid HBSAG Tests and FirstVue(TM) ...and was the preferred test in all phases of this evaluation CORAL SPRINGS, Fla., Oct. 13 /PRNewswire/ -- AT First Diagnostic LLC an emerging worldwide marketing leader in rapid diagnostic test ki


Campaign to End Fistula Quadruples In Size, Reaching Over 45 Countries, Says New Report
PRNewswire - October 13, 2008
NEW YORK, Oct. 13 /PRNewswire-USNewswire/ -- As the first-ever report by the United Nations Secretary-General, Ban Ki-Moon, on fistula is scheduled to be presented to Member States today, the Campaign to End Fistula announced a fourfold increase in the number of countries it serves. According to its annual report, the


Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General
PRNewswire - October 10, 2008
WALTHAM, Mass., Oct. 10 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (AMEX:IMA), a leading provider of near-patient diagnostics, monitoring and health management solutions, met yesterday with Ban Ki-moon, the Secretary-General of the United Nations, as part of a group of senior executives of seventeen


WEDNESDAY, OCTOBER 15TH IS NATIONAL LATINO AIDS AWARENESS DAY: LATINOS ACROSS THE UNITED STATES ARE URGED TO GET TESTED FOR HIV
PRNewswire - October 9, 2008
-- Additional Resources: Audio, hard copy requests, contact information and more available at: http://www.prnewswire.com/broadcast/35021/press.html NEW YORK, October 9 /PRNewswire/ -- This Is A Multivu Special Report Brought To You By Gilead Sciences . Last Month The Government Announced That The American Aids Epidemic


Earvin 'Magic' Johnson Responds to Radio Hosts' Accusations That He 'Faked AIDS'
PRNewswire - October 9, 2008
Today, in response to KTLK radio hosts Chris Baker and Langdon Perry s accusations that Magic faked AIDS, Entrepreneur, Philanthropist and NBA Legend Earvin Magic Johnson released the following statement. I am extremely disappointed in KTLK in Minneapolis. I am outraged that Chris Baker and Langdon Perry would minimize


Abbott Opens New Research Facility and Pilot Plant in Ludwigshafen
PRNewswire - October 9, 2008
LUDWIGSHAFEN, Germany , Oct. 9 /PRNewswire-FirstCall/ -- Abbott (NYSE:ABT) today announced the opening of new development laboratories and a pilot plant facility that will research groundbreaking technologies and test large-scale production of newly developed drug formulations. The expansion is part of Abbott s global


First European Survey to Study the Fit and Feel of Condoms: Condomerie Supports Indiana University in Online Survey
PRNewswire - October 9, 2008
AMSTERDAM, October 9/PRNewswire/ -- For the first time in Europe a study is being conducted among men to gain information about the fit and feel of condoms. The American Center for Sexual Health Promotion of Indiana University, urges men to participate in this survey and answer questions about their experiences using c


Miss Universe 2008 Dayana Mendoza Joins the Fight Against AIDS by Getting Tested for HIV
PRNewswire - October 9, 2008
NEW YORK, Oct. 9 /PRNewswire-USNewswire/ -- Miss Universe 2008 Dayana Mendoza demonstrates her commitment to the fight against AIDS, by getting publicly tested for HIV at the 6th annual National Latino AIDS Awareness Day 2008 kick-off event on October 9th at 4 p.m. at the Julia de Burgos Cultural Center located at 1680


In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices
PRNewswire - October 8, 2008
ALEXANDRIA, Va., Oct. 8 /PRNewswire-USNewswire/ -- The facts are overwhelming. Every day, nearly 7,000 people die from HIV/AIDS in sub-Saharan Africa. More than 35,000,000 women, children, and men in sub-Saharan Africa have already died of AIDS. The Foundation for Hospices in Sub-Saharan Africa is working to ensure the


Researchers to Evaluate a Once-Daily Investigational Dose of Raltegravir, Merck's Integrase Inhibitor, in an Investigational Population, Patients Previously Untreated for HIV-1
PRNewswire - October 7, 2008
-- QDMRK Once-Daily Raltegravir Study to be Conducted in 21 Countries Worldwide WHITEHOUSE STATION, N.J., Oct. 7 /PRNewswire/ -- Merck & Co. , Inc. today announced that researchers will conduct a clinical trial to evaluate the use of raltegravir tablets at a once-daily investigational dose in an investigational pop


Medicare Fraud Strike Force Indicts Eight Miami-Dade Residents for AIDS/HIV Infusion Fraud
PRNewswire - October 7, 2008
WASHINGTON, Oct. 7 /PRNewswire-USNewswire/ -- Eight Miami-Dade County residents have been charged in a 16-count indictment for their alleged roles in a Medicare fraud scheme involving fake HIV infusion treatments, Acting Assistant Attorney General of the Criminal Division Matthew Friedrich and U.S. Attorney for the Sou


Research Attributes Lack of HIV/AIDS Vaccine to Use of Chimpanzees
PRNewswire - October 6, 2008
BOSTON, Oct. 6 /PRNewswire-USNewswire/ -- A return to the use of chimpanzees in AIDS research and vaccine development is without scientific justification, according to a paper released today in the journal Alternatives to Laboratory Animals (ATLA). An Assessment of the Role of Chimpanzees in AIDS Vaccine Research concl


Sen. McCain Endorses National AIDS Strategy for the United States: Both Presidential candidates have now committed to developing a National AIDS Strategy if elected
PRNewswire - October 1, 2008
WASHINGTON, Oct. 1 /PRNewswire-USNewswire/ -- Presidential candidate Senator John McCain has committed to developing a National AIDS Strategy if elected President. The announcement came in written responses to questions from the Washington Blade newspaper. The full interview was posted on the newspaper s website today.


Improving Safety When Using Bone and Soft Tissue Allograft: Education and Communication are keys to ensuring patient safety and piece of mind
PRNewswire - October 1, 2008
ROSEMONT, Ill., Oct. 1 /PRNewswire-USNewswire/ -- Each year in the United States more than 1.3 million donated bone and bone-related allografts are successfully implanted in orthopaedic patients. Musculoskeletal allografts are frequently used in orthopaedic surgery to replace bones, tendons, or other soft tissues damag


The Death of Matthew Shepard
PRNewswire - October 1, 2008
-- TEN YEARS LATER: A FORUM ON GAY JOURNALISM MONDAY, OCTOBER 6, 2008 6:00 P.M. The Commonwealth Club of California 595 Market Street, 2nd Floor, San Francisco SAN FRANCISCO, Oct. 1 /PRNewswire/ -- Ten years ago, October 7, 1998, Matthew Shepard was brutally beaten on a road outside Laramie, Wyoming. Five days later he


Unprecedented 8th Year Start Up of National Direct AmeriCorps Program Access to Care Through Service (ACTS) Parent, Lead Organization The Philadelphia AIDS Consortium and World Health Care Infrastructures
PRNewswire - September 30, 2008
PHILADELPHIA, Sept. 30 /PRNewswire-USNewswire/ -- The following is being released by The Philadelphia AIDS Consortium: WHO: Parent Organization: The Philadelphia AIDS Consortium in partnership with its network of eleven (11) community-based organization sites located throughout the tri-state area. WHAT: Swearing-in of


Foundation for Biomedical Research Provides Free Scientific Enrichment Resources for Students: Downloadable Biomedical Research Puzzle Posters Teach Elementary, Middle and High School Students about the Stages of Research and Development
PRNewswire - September 30, 2008
WASHINGTON, Sept. 30 /PRNewswire-USNewswire/ -- The Foundation for Biomedical Research (FBR) announced today it will provide free, downloadable Biomedical Research Puzzle posters on its newly-designed Web site, http://www.fbresearch.org/. The complimentary puzzle posters teach elementary, middle and high school student


USAID | DELIVER PROJECT Expands Female Condom Order to 10 Million Units
PRNewswire - September 29, 2008
CHICAGO, Sept. 29 /PRNewswire-FirstCall/ -- The Female Health Company (AMEX:FHC) announced that it has received an order from John Snow, Inc., which implements the USAID | DELIVER PROJECT, for the delivery of up to 10 million female condoms (FC) for the United States Agency for International Development (USAID) support


AIDS Action Committee's MALE Center Salutes Creators and Honors First National Gay Men's HIV/AIDS Awareness Day
PRNewswire - September 26, 2008
State s only Sat. and Late-Night Free, Confidential, Rapid HIV Testing Site Serves Gay and Bisexual Men BOSTON, Sept. 26 /PRNewswire-USNewswire/ -- AIDS Action Committee of Massachusetts, Inc. (AAC) and its MALE Center in Boston s South End salute the National Association of People with AIDS (NAPWA) and AIDS Action Cou


Friends of the Global Fight Lauds Large-scale Actions Outlined at Today's 2008 MDG Malaria Summit
PRNewswire - September 25, 2008
The Global Fund Requests Approval of $1.62 Billion for Malaria Programs - If Granted, Universal Access to Bed Nets Achievable by 2010 NEW YORK, Sept. 25 /PRNewswire-USNewswire/ -- Friends of the Global Fight applauds commitments made at the 2008 MDG Malaria Summit, held in tandem with the annual United Nations assembly


Prix Galien USA Recognizes Biotech, Pharmaceutical Industries for Innovative Medical Treatments
PRNewswire - September 25, 2008
Awards for best biotechnology and best pharmaceutical agents honored outstanding drugs for treating cancer, HIV/AIDS and other life-altering diseases NEW YORK, Sept. 25 /PRNewswire-USNewswire/ -- Prix Galien USA 2008 (http://www.prix-galien-usa.com/) last night recognized the innovations and ingenuities of biotechnolog


Landmark Campaign Reaches Rural Kenyans with Tools to Prevent Malaria, Diarrhoeal Disease and HIV
PRNewswire - September 25, 2008
-- Voluntary HIV Counseling and Testing Campaign Provides Affordable and Efficient Approach to Preventing Disease Identified KAKAMEGA, Kenya , Sept. 25 /PRNewswire/ -- An important new approach to fighting malaria, diarrhoeal disease and HIV among adult men and women aged 15-49 has successfully been demonstrated for th


Obama and McCain Pledge Action on Global Poverty and Disease, Says Global AIDS Alliance Fund
PRNewswire - September 25, 2008
WASHINGTON, Sept. 25 /PRNewswire-USNewswire/ -- Today at the Clinton Global Initiative, Senators Obama and McCain spoke about why Americans, even in the context of financial crisis, should back bold action to end global disease and expand access to primary education. Each explained how aid was essential to strengthenin


Napo Pharmaceuticals Will Provide Pediatric Formulation of Crofelemer at Cost to Developing Nations to Help Treat Life-Threatening Diarrhoel Diseases (Subject to FDA Approval)
PRNewswire - September 25, 2008
-- Total Value of the Commitment to the CGI is an Estimated $210 Million -- Crofelemer, Once Approved for Children, Could Aid in Treating Diarrhoel Diseases That Kill An Estimated 2.5 million Children Each Year NEW YORK, Sept. 25 /PRNewswire-USNewswire/ -- Napo Pharmaceuticals, Inc., ( Napo ) of South San Francisco, Ca


Clinton Global Initiative Announces BD's Commitment to Biamba Marie Mutombo Hospital: BD collaborates with Dikembe Mutombo Foundation to improve healthcare system in the Democratic Republic of the Congo
PRNewswire - September 25, 2008
NEW YORK, Sept. 25 /PRNewswire-FirstCall/ -- The Clinton Global Initiative recognized BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, for its commitment to the Dikembe Mutombo Foundation (DMF) to enhance immune system monitoring and healthcare worker safety at the Biamba Mari


AIDS Activists from Across the Country Converge on Oxford, Mississippi, to Call on McCain and Obama to Commit to National AIDS Strategy
PRNewswire - September 24, 2008
OXFORD, Miss., Sept. 24 /PRNewswire-USNewswire/ -- As Senators Barack Obama and John McCain arrive in Oxford, Mississippi for their first presidential debate, they will be greeted by AIDS activists from across the country demanding that the next president develop a National AIDS Strategy within his first 100 days in of


Golf Legend Betsy King and LPGA Star Lorena Ochoa Help Raise More Than $130,000 For African Children: Next Stop Kilimanjaro
PRNewswire - September 24, 2008
-- Golf Fore Africa and World Vision Team Up for Fundraiser Betsy King Now Planning Fundraising Climb SEATTLE, Sept. 24 /PRNewswire-USNewswire/ -- At a weekend fundraiser at the Pine Canyon Club in Flagstaff, Arizona, LPGA legend Betsy King and her non-profit organization, Golf Fore Africa raised more than $130,000 to


Safe Blood for Africa Focuses on Rural DRC: Helping to Stop the Spread of HIV/AIDS by Providing Safe Blood for Transfusions to Rural Populations
PRNewswire - September 23, 2008
WASHINGTON, Sept. 23 /PRNewswire-USNewswire/ -- The Safe Blood for Africa Foundation (SBFA), a US-based non-profit organization, today released more details of its USAID-funded project to help improve the safety of blood used for transfusion in the Democratic Republic of the Congo (DRC). Begun one year ago, the DRC


AdvanDx Receives FDA 510(k) Clearance for Yeast Traffic Light PNA FISH(TM): New Product Provides First Capability To Rapidly Identify Five Candida Species Directly From Positive Blood Cultures In One Test
PRNewswire - September 23, 2008
WOBURN, Mass., Sept. 23 /PRNewswire/ -- AdvanDx today announced it received FDA 510(k) clearance of the Yeast Traffic Light PNA FISH(TM) to identify Candida yeast species directly from positive blood cultures. The Yeast Traffic Light(TM) is the latest addition to AdvanDx s easy-to-use, molecular-based PNA FISH(TM) diag


Canadian-Made Life Saving HIV/AIDS Drug Heading To Africa Under Canada's Access To Medicines Regime (CAMR)
PRNewswire - September 23, 2008
TORONTO, Sept. 23 /PRNewswire/ -- Apotex Inc, the largest Canadian-owned pharmaceutical company, is pleased to announce that Apo-TriAvir, a triple combination HIV/AIDS drug, approved under Canada s Access to Medicines Regime (CAMR), is ready to ship to Rwanda , the only country to make a request through a program tende


Arisyn Therapeutics Inc. Acquires Highly Novel Portfolio of Therapeutic Small Molecules for Infectious Disease and Cancer
PRNewswire - September 23, 2008
FREDERICK, Md., Sept. 23 /PRNewswire/ -- Arisyn Therapeutics Inc. (Arisyn) announced today day that it has successfully acquired from UAF Technologies and Research, L.L.C. (UTR) a series of highly novel small molecule inhibitors with a well-defined preclinical efficacy spectrum against a variety of infectious organisms


Napo Announces Positive Clinical Data Indicating Crofelemer, Could Effectively Treat Cholera
PRNewswire - September 22, 2008
SAN FRANCISCO, Sept. 22 /PRNewswire/ -- Napo Pharmaceuticals today announces positive clinical data on the effectiveness of crofelemer from a study for CRO-ID in treating severely ill cholera patients in conjunction with an antibiotic and rehydration therapy. A double-blind placebo-controlled study was conducted in one


AIDS Activists from Across the Country Converge on Oxford to Call on Presidential Candidates to Commit to National AIDS Strategy; Press Conference 9/23
PRNewswire - September 22, 2008
OXFORD, Miss., Sept. 22 /PRNewswire/ -- On Tuesday, September 23, caravans of AIDS activists from around the country will arrive in Oxford and greet hundreds of people who have walked 172 miles from Jackson - all to call on Sens. Barack Obama and John McCain to commit to a National AIDS Strategy within their first 100


CDC Expands Testing Recommendations for Chronic Hepatitis B Virus Infection: New Guidance Also Issued on Patient Management for Those Infected
PRNewswire - September 18, 2008
Sept. 18/PRNewswire-USNewswire - The U.S. Centers for Disease Control and Prevention (CDC) today published new recommendations for health care providers that are designed to increase routine testing in the United States for chronic hepatitis B, a major cause of liver disease and liver cancer. CDC recommends testing al


The Kaiser Family Foundation and Univision Launch First National Spanish-Language Media Campaign Featuring HIV-Positive Latinos and Loved Ones
PRNewswire - September 18, 2008
-- Groundbreaking Ads Confront Stigma and Debunk Myths in Response to Latino AIDS Crisis FORT LAUDERDALE, Fla., Sept. 18 /PRNewswire-USNewswire/ -- The Kaiser Family Foundation and Univision Communications Inc, the nation s leading Spanish-language media company today unveiled SOY... ( I AM... ), a groundbreaking Spani


Nation's Largest Human AIDS Ribbon Ceremony at the 2008 United States Conference on AIDS
PRNewswire - September 18, 2008
FORT LAUDERDALE, Fla., Sept. 18 /PRNewswire/ -- Who: The National Minority AIDS Council (NMAC) at the United States Conference of AIDS What: The group will attempt to create the Nation s Largest Living/Human AIDS Ribbon as Part Of their Annual Conference s Opening Ceremonies to Honor Those Working on the Frontlines of


Hundreds of AIDS Activists to March Across Brooklyn Bridge and Rally at City Hall to Demand National AIDS Strategy from Obama and McCain
PRNewswire - September 16, 2008
-- March and rally are part of national caravan to Mississippi for first presidential debate; activists will protest HIV/AIDS budget cuts in New York NEW YORK, Sept. 16 /PRNewswire-USNewswire/ -- On Thursday, September 18, 2008 hundreds of AIDS activists will march across the Brooklyn Bridge and hold a rally at New Yor


Unique Experiment Finds Health Content Placed in Grey's Anatomy Episode Quadrupled Awareness Among Audience, Over Eight Million People Absorbed Key Health Message From the Show
PRNewswire - September 16, 2008
-- Broader Analysis of Three Years of Top Ten Prime Time Television Shows Indicates Nearly Six in Ten Episodes Featured a Health Storyline WASHINGTON, Sept. 16 /PRNewswire-USNewswire/ -- Most viewers who tune in each night to television s top-rated sitcoms and dramas do so because they want to be entertained, but accor


Successful Results for Mymetics Corporation's Mucosal HIV/AIDS Vaccine Viral Challenge Significantly Exceeds Expectations
PRNewswire - September 16, 2008
NYON, Switzerland , September 16/PRNewswire-FirstCall/ -- Mymetics Corporation (OTCBB: MYMX), a vaccine development company, is pleased to announce their preliminary SHIV challenge results on non-human primates previously immunized with the Company s mucosal HIV-AIDS vaccine designed for triggering mucosal protection.


U.S. Surrogacy Firm to Provide Private Consultations in the UK for Prospective Parents
PRNewswire - September 16, 2008
LOS ANGELES, Sept. 16 /PRNewswire/ -- Growing Generations, the largest U.S. based surrogacy agency, is coming to London, England in October to perform private consultations with prospective clients. The agency has successfully worked with 15 UK-based families who now have children, and an additional 12 who are going th


'Project Runway' Fashion Designer Launches Living Positive By Design Campaign in Miami/Ft. Lauderdale to Educate About Living with HIV and to Combat Stigma
PRNewswire - September 15, 2008
Jack Mackenroth, from the hit reality television series Project Runway will kick-off a national HIV and AIDS education campaign called Living Positive By Design in Miami/Ft. Lauderdale during an exclusive event held at the 2008 United States Conference on AIDS (USCA), sponsored by the National Minority AIDS Council (NM


Integrated Prevention Demonstration Campaign Launched in Western Kenya to Fight HIV, Malaria and Diarrhoeal Disease
PRNewswire - September 15, 2008
-- Innovative Campaign Breaks Down Policy and Funding Barriers and Paves Way for Affordable and Efficient Approach KAKAMEGA, Kenya , Sept. 15 /PRNewswire/ -- A new approach to fighting malaria, diarrhoeal diseases and HIV was launched today in the Western Kenyan district of Kakamega in Lurambi division. The new cam


CDC Reports High HIV Infection Rates in Communities of Color, Men Who Have Sex With Men
PRNewswire - September 12, 2008
-- AIDS Action Committee Emphasizes Need for Targeted Prevention Outreach BOSTON, Sep. 12 /PRNewswire-USNewswire/ -- The U.S. Centers for Disease Control and Prevention (CDC) yesterday released a new report showing the uneven and devastating impact of HIV on communities of color and men who have sex with men (MSM). Th


AIDS Activists to March 172 Miles from Jackson to Oxford Presidential Debate to Demand National AIDS Plan from Next President
PRNewswire - September 12, 2008
-- 172-mile march reprises historic 1966 Walk Against Fear that mobilized Black vote; rallies and town hall meetings planned along march route; James Meredith to Speak JACKSON, Miss., Sept. 12 /PRNewswire-USNewswire/ -- People living with HIV/AIDS, their loved ones and other supporters will march from Jackson to Oxford


ADA Amendments Act Will Restore Vital Civil Rights Protections for Americans With Physical and Mental Disabilities
PRNewswire - September 11, 2008
WASHINGTON, Sept. 11 /PRNewswire-USNewswire/ -- The leaders of a national coalition of disability, civil rights and social justice organizations praised the U.S. Senate today for taking bipartisan action to restore vital civil rights protections under the Americans with Disabilities Act (ADA). In recent years, the ADA


Two Miami Physicians Plead Guilty and Admit Ordering $6.8 Million Worth of Unnecessary HIV Infusion Treatments
PRNewswire - September 11, 2008
WASHINGTON, Sept. 11 /PRNewswire-USNewswire/ -- Miami physicians, Carlos Contreras, M.D., and Ramon Pichardo, M.D., each pleaded guilty today to defrauding the Medicare program in connection with a $6.8 million HIV infusion fraud scheme, Acting Assistant Attorney General Matthew Friedrich of the Criminal Division and U


Proposed Class Action Settlement Provides Consumers, Medicare Recipients, and Insurers With Money Back
PRNewswire - September 11, 2008
BOSTON, Sept. 11 /PRNewswire-USNewswire/ -- The United States District Court for the District of Massachusetts has granted preliminary approval of a Proposed Settlement related to the average wholesale prices of certain prescription drugs. In the lawsuit, In re: Pharmaceutical Industry Average Wholesale Price Litigatio


Internews Enlists More Than 1,000 Journalists in Fight Against HIV/AIDS
PRNewswire - September 10, 2008
ARCATA, Calif., Sept. 10 /PRNewswire/ -- In some countries, lime juice is thought to ward off HIV/AIDS. In others, homosexuality is not publicly discussed. Against such a backdrop of misinformation and stigma, how can developing countries fight a virus that has already killed tens of millions of people? Part of the ans


African Diplomat's and Former Olympian's Daughter Suzanne Africa Engo Announces 'Africa 101 Project' - Her 858-Mile Run from New York to Chicago
PRNewswire - September 10, 2008
NEW YORK, Sept. 10 /PRNewswire/ -- WHAT: 858-Mile Solo Ultra Marathon Kickoff: CAUSE MEDIA GROUP & NY AIDS FILM FESTIVAL WHO: Hit R&B Artist MAXWELL kicks off event with BERTIL LINDBLAD, Director UNAIDS NYO; KENNETH PODZIBA, NYC Sports Commissioner, on behalf of Mayor Bloomberg; TOBY TANSER, Shoe4Africa; and ce


Miami HIV Clinic Administrator Pleads Guilty for Role in a $14 Million Medicare Fraud Scheme
PRNewswire - September 9, 2008
WASHINGTON, Sept. 9 /PRNewswire-USNewswire/ -- Miami resident Dilcia Marinez, 57, pleaded guilty today to her role in defrauding the Medicare program and laundering the proceeds of the crimes in connection with a $14 million HIV infusion fraud scheme, Acting Assistant Attorney General Matthew Friedrich of the Criminal


VivaGel(R) Condom: Full Licence Agreement With Durex(R)
PRNewswire - September 9, 2008
MELBOURNE, Australia , Sept. 9 /PRNewswire/ -- Starpharma Holdings Limited today announced that a full licence agreement has been signed with SSL International plc in relation to the VivaGel(R) coated condom. SSL manufactures and sells Durex(R) condoms, the market-leading condom brand worldwide. Under the terms of


NCPS Outraged at HIV/AIDS Medi-Cal Cuts
PRNewswire - September 9, 2008
MEMPHIS, Tenn., Sept. 9 /PRNewswire-USNewswire/ -- The National Coalition of Pastors Spouses (NCPS) is outraged at the proposed cuts to the HIV/AIDS Medi-Cal pilot program which was designed to help provide life-sustaining medications for thousands of Californians living with HIV/AIDS. These cuts are especially troubli


New HIV Protection for Women
PRNewswire - September 9, 2008
MANCHESTER, England, September 9/PRNewswire/ -- Vaginal rings, similar to those used for contraception and hormone replacement therapy, could protect women from sexually-transmitted HIV, according to research presented at the British Pharmaceutical Conference (BPC) in Manchester. Researchers from the School of Pharmacy


Ortho Biotech Files sNDA for DOXIL(R) for the Treatment of Advanced Breast Cancer
PRNewswire - September 8, 2008
BRIDGEWATER, N.J., Sept. 8 /PRNewswire/ -- Ortho Biotech Products, L.P. today announced that the Company has submitted a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration ( FDA ) for the combination of DOXIL (R) (doxorubicin HCl liposome injection) and Taxotere(R) (docetaxel)* for the t


Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders
PRNewswire - September 8, 2008
-- 90% of genotype 2 or 3 patients achieve undetectable HCV RNA levels following 4 weeks of treatment with R7128 1500mg BID with Pegasys(R) plus Copegus(R) -- Safety and tolerability comparable to placebo administered with Pegasys plus Copegus PRINCETON, N.J., Sept. 8 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (NASDAQ:


Domestic AIDS Epidemic Ignored at Republican National Convention: Advocates call on John McCain to commit to develop a National AIDS Strategy for the U.S.
PRNewswire - September 5, 2008
MINNEAPOLIS and ST. PAUL, Minn., Sep. 5 /PRNewswire-USNewswire/ -- The Republican National Convention concluded last night with no mention of the domestic AIDS epidemic in the United States and only passing reference to the epidemic overseas. Neither Presidential nominee Sen. John McCain nor Vice Presidential nominee G


The HealthCentral Network Acquires TheBody.com, the Number One Interactive Resource for HIV Communities
PRNewswire - September 4, 2008
-- Site brings highest quality, largest audiences of patients concerned about HIV prevention and treatment, and a unique connection with HIV-focused physicians ARLINGTON, Va., Sept. 4 /PRNewswire/ -- The HealthCentral Network, Inc. (www.HealthCentral.com) today announced the acquisition of HIV/AIDS patient resource The


Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients
PRNewswire - September 4, 2008
-- 100 mg cohort demonstrates potent antiviral activity and favorable safety profile CAMBRIDGE, Mass., Sept. 4 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious disease


More than 1,000 Journalists Enlisted in Fight Against HIV/AIDS
PRNewswire - September 4, 2008
WASHINGTON, Sept. 4 /PRNewswire/ -- In some countries, lime juice is thought to ward off HIV/AIDS. In others, homosexuality is not publicly discussed. Against such a backdrop of misinformation and stigma, how can developing countries fight a virus that has already killed tens of millions of people? Part of the answer i


FDA Approves First Hepatitis B Viral Load Test
PRNewswire - September 4, 2008
-- Another Roche first in TaqMan(R) real-time PCR testing for the diagnostic lab PLEASANTON, Calif., Sept. 4 /PRNewswire/ -- The U.S. Food & Drug Administration ( FDA ) has approved the Roche COBAS(R) TaqMan(R) HBV Test, the first assay for quantitating Hepatitis B Virus DNA approved in the U.S. The test uses Roche


Senator Frist and Convention Delegates Support AIDS-Affected People Around the World, Raise Funds for Gustav Evacuees
PRNewswire - September 2, 2008
-- Delegates Join World Vision, ONE to Build Hope and Give Help MINNEAPOLIS, Sept. 2 /PRNewswire-USNewswire/ -- Delegates to the Republican Party Convention are sending a message to the most vulnerable communities around the world including evacuees in the Gulf Coast region and those suffering from HIV and AIDS in deve


InterMune Earns Development Milestone in HCV Protease Inhibitor Collaboration With Roche
PRNewswire - September 2, 2008
-- $15 million development milestone payment to InterMune -- Roche to lead ITMN-191 program in Phase 2 BRISBANE, Calif., Sept. 2 /PRNewswire-FirstCall/ -- InterMune, Inc. (NASDAQ:ITMN) today announced that InterMune has earned a $15 million development milestone under its development collaboration with Roche for the he


The Female Health Company Receives Order for 4.3 Million FC2 Female Condoms for Papua New Guinea
PRNewswire - September 2, 2008
CHICAGO, Sept. 2 /PRNewswire-FirstCall/ -- The Female Health Company (AMEX:FHC) which manufactures and markets the FC and FC2 Female Condoms(R), today announced it has received an order for 4.3 million FC2s from the Papua New Guinea - Australia HIV and AIDS program.


PhRMA Members Lead the World in Cancer Research Investment
PRNewswire - September 2, 2008
WASHINGTON, Sept. 2 /PRNewswire-USNewswire/ -- The Pharmaceutical Research and Manufacturers of America (PhRMA) applauds the leadership of television news anchors Katie Couric, Charles Gibson and Brian Williams and the commitment of their respective networks in donating one hour of primetime programming on Sept. 5 to S


AIDS Responsibility Project Invites You to Join Us for a Panel Discussion During the RNC Convention: After the Welfare State, and After the Katrina Disaster
PRNewswire - August 31, 2008
-- How Social Entrepreneurs and Corporations are Bringing Business Solutions To solve our Nation s Public Policy Challenges MINNEAPOLIS, Aug. 31 /PRNewswire-USNewswire/ -- Monday, September 1, 2008 -- Marquette Hotel, 710 Marquette Ave -- Lunch will be served, Program Begins at 12:30PM Few policy leaders would defend t


Abbott Fund to Build First Pediatric HIV/AIDS Clinic in Tanzania
PRNewswire - August 29, 2008
-- Joint Effort with Baylor International Pediatric AIDS Initiative Will Improve Access to Health Care for Children with HIV/AIDS WASHINGTON, Aug. 29 /PRNewswire-FirstCall/ -- The Abbott Fund joined representatives from the U.S. government, Baylor College of Medicine, the government of Tanzania and other part


Bill Clinton and Other Leaders Call For 'Renewal of Battle Against AIDS' in the United States at Democratic Convention: Advocates disappointed that Obama failed to address the issue
PRNewswire - August 29, 2008
DENVER, Aug. 29 /PRNewswire-USNewswire/ -- Speaking at the Democratic National Convention Wednesday night, Former President Bill Clinton called for a reinvigorated response to the domestic HIV/AIDS epidemic in the United States . In praising Presidential nominee Barack Obama, Clinton said, He will continue and enhance


Bristol-Myers Squibb Welcomes NICE Guidance Recommending Baraclude(R) (entecavir) as a Treatment Option for Chronic Hepatitis B
PRNewswire - August 29, 2008
UXBRIDGE, England, August 29/PRNewswire/ -- NICE (National Institute for Health and Clinical Excellence) has published guidance that recommends Baraclude(R) (entecavir) as an option for treatment of eligible patients with chronic hepatitis B (CHB). Entecavir is a potent anti-viral treatment for chronic Hepatitis B that


INTELENCE(TM) (Etravirine) Receives Marketing Authorisation in the European Union for HIV Combination Therapy
PRNewswire - August 29, 2008
-- INTELENCE is the First NNRTI to Show Antiviral Activity in Patients With NNRTI-Resistant Virus CORK, Ireland , August 29/PRNewswire/ -- The European Medicines Agency (EMEA) has granted marketing authorisation for the anti-HIV medication INTELENCE(TM) (etravirine). INTELENCE is a next generation non-nucleoside revers


Preliminary Report of American Biotech Labs HIV Study Featured in Inaugural Issue of Journal of the Science of Healing Outcomes
PRNewswire - August 29, 2008
Four-month study detailing effects of treatment of HIV-positive individuals with American Biotech Labs (ABL) ASAP 10 treatment indicates significant improvement in the condition of the subjects after treatment; in-vitro laboratory work shows that ABL nanosilver particles can block entry of the virus into cells, eventua


Convicted Medicare Fraud Defendant Pleads Guilty to Laundering More Than $3 Million in Fraudulent Proceeds
PRNewswire - August 29, 2008
WASHINGTON, Aug. 29 /PRNewswire-USNewswire/ -- Miami resident Juan Carlos Castaneda, 47, pleaded guilty today to participating in a conspiracy to launder approximately $3.8 million in proceeds from several Medicare fraud schemes, Acting Assistant Attorney General Matthew Friedrich of the Criminal Division and U.S. Atto


New Research Reveals That Mycamine(R) is an Effective Treatment in Children, Young Babies and Premature Infants
PRNewswire - August 28, 2008
-- Research Adds to Already Demonstrated Efficacy in Adult Population -- Not for distribution in the United Kingdom STAINES, England, August 28/PRNewswire/ -- Parents and paediatricians are today welcoming the results of new research that adds additional support for an effective and well tolerated treatment for childre


Panic At The Disco and Plain White T's to Take the Stage at the Rock Band 2 Party to Benefit LIFEbeat Saturday, September 6th at House of Blues in Los Angeles
PRNewswire - August 28, 2008
NEW YORK, Aug. 28 /PRNewswire/ -- Rock Band 2 -- the next incarnation of the cultural and video game phenomenon Rock Band -- is teaming up with LIFEbeat to shed some star power over the continued need for HIV/AIDS prevention in the week prior to the game s launch. On Saturday, September 6th at House of Blues in Los Ang


AIDS Crisis in Communities of Color Prompts Demand for National Plan to Fight HIV/AIDS
PRNewswire - August 27, 2008
-- Public Health Advocates Deliver Demand during the Democratic National Convention Calling on Senators Barack Obama and John McCain to Support a Comprehensive National AIDS Strategy LOS ANGELES, Aug. 27 /PRNewswire-USNewswire/ -- In a historically unprecedented move, over 30 national HIV/AIDS organizations and leaders


Daschle, Convention Delegates, Daughtry Join to Give Help to AIDS-Affected People Around the World
PRNewswire - August 26, 2008
-- Delegates Join World Vision, ONE to Build Hope, Give Help Around the World DENVER, Aug. 26 /PRNewswire-USNewswire/ -- Delegates to the Democratic Party Convention are sending a message to people suffering from HIV and AIDS around the world: We want to help. Doing something unconventional at the party s presidential


Half of Surveyed Physicians Expect to Replace Between 6 Percent and 15 Percent of Their Sustiva Prescriptions with Isentress: Most Surveyed MCO Pharmacy Directors Do Not Place Cost Control Measures on Branded Antiretroviral Drugs, According to a New Report from Decision Resources
PRNewswire - August 26, 2008
WALTHAM, Mass., Aug. 26 /PRNewswire/ -- Decision Resources, one of the world s leading research and advisory firms for pharmaceutical and healthcare issues, finds that the expansion of labeling for Merck s Isentress to include use in treatment naive patients will significantly impact sales of the drug for HIV treatment


Here's Hope and the AIDS Epidemic in the South
PRNewswire - August 25, 2008
-- I was working in Miami, renting a room, and getting by alone. Then my body started breaking down. Because of my weak HIV-positive system, my diabetes and my hypertension kicked up and I couldn t work. I couldn t make rent, so I ended up homeless. The South Florida AIDS Network led me to Here s Hope and that s where


Congressional Leadership Awards at DNC Honor Commitment to Fight HIV/AIDS
PRNewswire - August 25, 2008
-- Calls for Congressional Candidates to Support National AIDS Strategy DENVER, Aug. 25 /PRNewswire-USNewswire/ -- Today, Spreading Hope: Congressional Leadership Awards in the Fight Against HIV/AIDS luncheon occurs during the Democratic National Convention at the Hotel Monaco


Democrats to be Recognized in Denver for Leadership on HIV/AIDS
PRNewswire - August 25, 2008
-- All Candidates for Congress Asked to Sign Pledge on AIDS and Poverty DENVER, Aug. 25 /PRNewswire-USNewswire/ -- In a luncheon today in Denver, two leading AIDS organizations are recognizing Democratic members of Congress who have shown extraordinary leadership in the fight against HIV/AIDS, both in the US and around


WashingtonWatch.com Weekly Update: Senator Biden's Priorities
PRNewswire - August 25, 2008
WASHINGTON, Aug. 25 /PRNewswire-USNewswire/ -- This is the WashingtonWatch.com federal legislative update for the week of August 25, 2008. Congress continues its August recess and will not return to Washington for a couple more weeks. This week, the Democratic party convention in Denver will complete the process of sel


AltaMed Opens First-of-its-Kind Health Care Center in the Nation: 32,000 Sq. Ft. Facility Helps Tackle Health Care Crisis by Providing Sorely Needed Medical, Dental and Senior Services to Critically Underserved Area of Los Angeles County
PRNewswire - August 22, 2008
LOS ANGELES, Aug. 22 /PRNewswire/ -- AltaMed Health Services along with community and political leaders, celebrated today the grand opening of the Family Health and Wellness Center located in the heart of El Monte. With a population in critical need of health care services, the Family Health and Wellness Center represe


Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000: 9,395 Women Enrolled in Trial Sponsored by Medical Research Council
PRNewswire - August 22, 2008
LEXINGTON, Mass., Aug. 22 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc. (NASDAQ:IDEV) announced today the completion of enrollment in Protocol MDP 301, a Phase III clinical trial of PRO 2000, the Company s candidate vaginal microbicide for the prevention of HIV and other sexually transmitted infections. The t


Medical Policy Guideline for Trofile(TM) Established By Wellpoint, Inc.: Licensee of Blue Cross/Blue Shield in fourteen states establishes guidelines for use of Trofile
PRNewswire - August 20, 2008
SOUTH SAN FRANCISCO, Calif., Aug. 20 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. (Nasdaq: MGRM) today announced that Wellpoint, Inc. has established a national Medical Policy Guideline for Monogram s Trofile Assay. Wellpoint s guidelines provide that HIV tropism testing with Trofile is considered medically nec


TheraQuest Presents Topical Local Anesthetic and Abuse Deterrence Data at the World Congress on Pain
PRNewswire - August 20, 2008
BLUE BELL, Pa., Aug. 20 /PRNewswire/ -- TheraQuest Biosciences, Inc. a development stage pain management company is presenting data today on TQ-1019, its proprietary topical local anesthetic and on SECUREL(R), its abuse deterrent technology at the World Congress on Pain in Glasgow, Scotland. TheraQuest will present fou


Rosetta Genomics and the National Institute of Health (NIH) to Identify Potential MicroRNA Drug Targets for HIV: Collaboration Will Seek to Identify microRNAs Implicated in HIV Viral Replication and Their Function
PRNewswire - August 20, 2008
-- Samples Will be Screened and Analyzed Using Rosetta Genomics Proprietary microRNA Technologies REHOVOT, Israel and JERSEY CITY, New Jersey, August 20 /PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDQ: ROSG) announced today a collaboration with the National Institute of Health to identify microRNAs involved in


New HIV Prevention/Anti-Stigma Campaign Featuring HIV Positive & Negative Persons 'TOGETHER' Launches Across the Nation
PRNewswire - August 19, 2008
SAN FRANCISCO, Aug. 19 /PRNewswire/ -- TOGETHER ... HIV STOPS WITH US is the message of the new media campaign launching today in areas across the country including: Boston, Long Beach and Alameda County, CA. Billboards, transit ads, posters featuring real HIV positive people, and a wide spectrum of HIV negative person


Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
PRNewswire - August 19, 2008
SAN DIEGO, Aug. 19 /PRNewswire-FirstCall/ -- Vical Incorporated (NASDAQ:VICL) today announced a research collaboration with the Karolinska Institute, a leading European medical university, and the Swedish Institute for Infectious Disease Control (SMI), a governmental expert agency, to evaluate Vical s Vaxfectin(R) adju


Tobira Therapeutics Inc. Receives US Patent for TBR-652: Clinical trial currently in Phase I
PRNewswire - August 18, 2008
PRINCETON, N.J. and SAN DIEGO, Aug. 18 /PRNewswire/ -- Tobira Therapeutics Inc., a clinical stage biotechnology company committed to the research and product discovery against life-threatening and life-altering infectious diseases, today announced the issuance of Patent No. 7,371,772 B2 by the U.S. Patent and Trademark


Aureus Pharma Releases New Unified Knowledge Database: AurSCOPE(R) Global Pharmacology Space and Drug Target Knowledge Databases Related to Nuclear Receptors and Proteases
PRNewswire - August 18, 2008
PARIS, August 18/PRNewswire/ -- Aureus Pharma, a leading provider of knowledge management solutions that accelerate life sciences discovery, announced today the release of three new AurSCOPE(R) Target knowledge databases. The new offerings include knowledge databases for the important drug targets Nuclear Receptor and


Diplomat Specialty Pharmacy Partners With NeedyMeds.com to Increase Drug Access
PRNewswire - August 18, 2008
SWARTZ CREEK, Mich., Aug. 18 /PRNewswire/ -- Diplomat Specialty Pharmacy announced today that they have entered into a corporate agreement with NeedyMeds.com, an online data base listings of available financial assistance programs for patients requiring support with drug access. The mission of Diplomat s dedicated fund


The Scientific Business of Thomson Reuters Publishes Three Pharma Matters Reports Covering the First Quarter of 2008
PRNewswire - August 18, 2008
-- Quarterly Reports use Market Intelligence and Competitive Analysis from Thomson Reuters to Explore Various Aspects of the Pharmaceutical Pipeline LONDON and PHILADELPHIA, Aug. 18 /PRNewswire/ -- Thomson Reuters, the world s leading source of intelligent information for businesses and professionals, has announced the


Ardea Biosciences Announces Progress of Clinical Development Programs and Reports Second Quarter and Year-to-Date 2008 Financial Results
PRNewswire - August 14, 2008
SAN DIEGO, Aug. 14 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (NASDAQ:RDEA), a company focused on the discovery and development of small-molecule therapeutics for the treatment of human immunodeficiency virus (HIV), gout, cancer and inflammatory diseases today reported recent accomplishments and financial result


Nasal Hepatitis B Vaccine Elicits Robust Immunity With a Single Dose; Confers Major Advantages Over Traditional Vaccines: Study reported in August issue of journal PLoS One
PRNewswire - August 13, 2008
ANN ARBOR, Mich., Aug. 13 /PRNewswire/ -- A new study has shown that a nasal hepatitis B vaccine elicits a dramatic immune response in animals without requiring three vaccinations, sterile syringes or refrigeration-three factors that impede the delivery of current hepatitis B vaccines. In the study, a single dose of th


FDA Grants Full Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay - Test Cleared to Screen Donated Blood for Hepatitis B, as well as HIV-1 and Hepatitis C, on Fully and Semi-Automated Instrument Systems
PRNewswire - August 13, 2008
SAN DIEGO, Aug. 13 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the US Food and Drug Administration ( FDA ) has approved its supplemental regulatory application to use the PROCLEIX(R) ULTRIO(R) assay to screen donated blood for the hepatitis B virus (HBV). The FDA had previously


National Healthcare for Homeless Day: August 13th, 2008: St. Anthony's Battles Highest Rate of TB Infection in U.S.
PRNewswire - August 12, 2008
SAN FRANCISCO, Aug. 12 /PRNewswire/ -- San Francisco has the highest rate of tuberculosis (TB) in the U.S., with recurrent outbreaks among the homeless and marginally housed, according to the most recent study on homelessness and TB by Harvard Medical School. Additionally, the Tenderloin has the highest rates of TB in


GeoVax Labs, Inc. Announces Six Month Financial Results and Provides Operational Update
PRNewswire - August 11, 2008
ATLANTA, Aug. 11 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (BULLETIN BOARD: GOVX) , an Atlanta-based, biopharmaceutical firm (the Company), developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced its financial results and provided an operation


Moujan Vahdat Opens Community United Empowerment Pavilion: The Grand Opening Of A New Housing Facility Aims To Improve The Lives Of New Yorkers Living With HIV/AIDS
PRNewswire - August 11, 2008
NEW YORK, Aug. 11 /PRNewswire/ -- Each year thousands of New Yorkers are diagnosed with HIV/AIDS leaving them scared and uncertain as to what their future holds. That unfortunate reality prompted New York real estate magnate Moujan Vahdat, one of the largest landowners in New York, to lend a hand by funding a housing f


Inverness Medical Innovations Features Innovative TB Diagnostic - Clearview(R) TB ELISA at AIDS 2008
PRNewswire - August 8, 2008
WALTHAM, Mass., Aug. 8 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (AMEX:IMA), a leading provider of near-patient diagnostics, monitoring and health management solutions, is featuring its new TB diagnostic test, the Clearview TB ELISA, at the International AIDS conference (AIDS 2008). The test, which


Abbott Study Shows Investigational Heat-Stable Norvir(R) Tablet Provides Similar Drug Levels to Current Norvir Capsule
PRNewswire - August 7, 2008
-- Pivotal Study of Norvir Tablet Bioavailability Will Form the Basis of Request for Priority Regulatory Review MEXICO CITY, Aug. 7 /PRNewswire-FirstCall/ -- Abbott (NYSE:ABT) presented pivotal data at the XVII International AIDS Conference (AIDS 2008) in Mexico City today showing that its investigational Norvir(R) (


Ardea Biosciences Presents Phase 2a Antiviral Activity Data for Lead HIV Candidate, RDEA806 at XVII International AIDS Conference
PRNewswire - August 7, 2008
MEXICO CITY and SAN DIEGO, Aug. 7 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (NASDAQ:RDEA) today announced that data was presented from its completed Phase 2a proof-of-concept monotherapy study of RDEA806, the Company s novel investigational non-nucleoside reverse transcriptase inhibitor (NNRTI) for patients wit


Analysis of Six Clinical Trials Finds EPZICOM(R) Effective in Treatment-Naive HIV Patients With Both High and Low Baseline Viral Loads
PRNewswire - August 7, 2008
MEXICO CITY, Aug. 7 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE:GSK) announced that a retrospective analysis of six clinical trials found that anti-HIV regimens containing EPZICOM ( abacavir + lamivudine) were effective in treatment-naive patients regardless of baseline viral loads.


Head-to-Head 96-Week Study Shows EPZICOM(R) is Comparable to Truvada(R) in Efficacy and Safety Measures in HIV Treatment-Naive Patients
PRNewswire - August 7, 2008
MEXICO CITY, Aug. 7 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE:GSK) today announced that 96-week data from the HEAT study show that once-daily EPZICOM ( abacavir + lamivudine) provides comparable efficacy to once-daily Truvada (R) (


Inverness Medical Innovations Announces 4th Generation Rapid HIV Test - Determine(TM) HIV-1/2 Ag/Ab Combo
PRNewswire - August 7, 2008
WALTHAM, Mass., Aug. 7 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (AMEX:IMA), a leading provider of near-patient diagnostics, monitoring and health management solutions, has announced the introduction of its new 4th generation rapid HIV diagnostic test, the Determine HIV-1/2 Ag/Ab Combo, at the Inter


Thousands Rally in Mexico City and Call for Human Rights Protections in Global AIDS Response
PRNewswire - August 7, 2008
MEXICO CITY, Aug. 7 /PRNewswire/ -- Thousands of AIDS activists gathered today for the first-ever international rally for human rights and HIV/AIDS, a key event of the XVII International AIDS Conference. The activists called on governments to ensure greater human rights protections for people living with HIV and those


President and Mrs. Bush Visit USAID Programs in Thailand
PRNewswire - August 7, 2008
WASHINGTON, Aug. 7 /PRNewswire-USNewswire/ -- The President and First Lady traveled to Thailand to celebrate 175 years of U.S.-Thai relations and to discuss bilateral and regional issues with Prime Minister Samak. During their stay, the President visited an AIDS hospice supported by the U.S. Agency for International De


Tracleer(R) (bosentan) Receives EU Approval for Treatment of Patients With Mildly Symptomatic Pulmonary Arterial Hypertension
PRNewswire - August 6, 2008
ALLSCHWIL and BASEL, Switzerland , August 6/PRNewswire/ -- Actelion Ltd (SWX: ATLN) announced today that Tracleer(R) (bosentan), a dual endothelin receptor antagonist, has been approved in the European Union for the treatment of patients with mildly symptomatic pulmonary arterial hypertension (PAH WHO functional class


Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk of Heart Attack With Abacavir Therapy
PRNewswire - August 6, 2008
MEXICO CITY, Aug. 6 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE:GSK) (GSK) announced today that a review of data from over 14,600 patients in 54 clinical studies showed no increased risk of myocardial infarction associated with the anti-HIV medication abacavir. GSK conducted this review upon learning that the analy


ImQuest Receives $6.4 M Five Year Award from NIH to Develop Long-Lasting Combination Topical Microbicides To Prevent HIV Transmission
PRNewswire - August 6, 2008
FREDERICK, Md., Aug. 6 /PRNewswire/ -- ImQuest BioSciences announced today the successful acquisition of funding from the National Institutes of Health to support the development of a long lasting, safe, and acceptable combination topical microbicide product. ImQuest and a consortium of microbicide researchers from fou


Pastor Rick & Kay Warren Bring Together Leaders to Discuss Unification of Expertise to Stop HIV/AIDS: Saddleback Church Hosts International AIDS Conference Satellite Session on the Partnership of Government, Business & the Church
PRNewswire - August 6, 2008
MEXICO CITY, Aug. 6 /PRNewswire/ -- Kay Warren, HIV/AIDS advocate, author and executive director of the Saddleback HIV/AIDS Initiative, moderated a panel of Rwandan government and church leaders; business and medical experts; and Saddleback HIV/AIDS Initiative directors; along with her husband, Rick Warren, founding pa


National Quality Forum Endorses National Consensus Standards Promoting Accountability and Public Reporting: Standards emphasize measurement gaps and harmonization
PRNewswire - August 5, 2008
WASHINGTON, Aug. 5 /PRNewswire-USNewswire/ -- To fill gaps in assessing clinician performance that can promote higher quality health care, the National Quality Forum (NQF) has endorsed 67 clinician-level consensus standards relating to cancer care, infectious diseases, perioperative care, and care provided by thousands


Leading AIDS Experts Urge Greater Focus on Behavior-Change Programs to Prevent HIV - Report: Hundreds of Studies Show that Programs to Curb Unsafe Sex and Drug Use are Highly Effective, but Often Overlooked in Global AIDS Response
PRNewswire - August 5, 2008
MEXICO CITY, Aug. 5 /PRNewswire/ -- In a new report released today, an international panel of AIDS experts calls on global leaders to aggressively expand HIV prevention programs aimed at reducing high-risk behaviors, including unsafe sex and drug use. Citing hundreds of clinical trials and observational studies, the re


Landmark HIV/AIDS Publication Launches at International AIDS Society Conference in Mexico City - "From the Ground Up: Building Comprehensive HIV/AIDS Care Programs in Resource-Limited Settings" Features Work of More Than 230 Global Health Experts
PRNewswire - August 5, 2008
MEXICO CITY, Aug. 5 /PRNewswire-USNewswire/ -- The Elizabeth Glaser Pediatric AIDS Foundation, with support from the A Day in the Life of Africa Foundation/Tides Foundation, the U.S. Government, Harvard University and others, unveiled today a comprehensive guide to improving and expanding HIV/AIDS prevention, care and


amfAR Urges Iran to Release Missing HIV/AIDS Doctors
PRNewswire - August 5, 2008
-- CEO of amfAR, The Foundation for AIDS Research, calls the reported detention of two Iranian doctors known for their pioneering work on HIV/AIDS extremely troubling. NEW YORK, Aug. 5 /PRNewswire-USNewswire/ -- Kevin Robert Frost, CEO of amfAR, The Foundation for AIDS Research, expressed deep concern today over the re


Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines: HIV-Infected Women and Non-Whites New to Antiretroviral Therapy Respond Similarly to Men and Whites
PRNewswire - August 5, 2008
MEXICO CITY, Aug. 5 /PRNewswire-FirstCall/ -- Initial treatment regimens containing once-daily or twice-daily dosing of Abbott s (NYSE:ABT) protease inhibitor Kaletra (R) ( lopinavir / ritonavir ) tablet provided similar results for controlling the v


Jesse Milan to Address 2008 International AIDS Conference
PRNewswire - August 5, 2008
-- Jesse Milan, Altarum Institute VP and Chairman of the Black AIDS Institute, to be Keynote Speaker at Mexico City Business Council on AIDS WASHINGTON, Aug. 5 /PRNewswire/ -- Jesse Milan, Jr., Vice President of Altarum Institute and a prominent leader and advocate on HIV/AIDS issues, will address the 2008 Mexico City


Ninety-Six Week Data on Tibotec Investigational NNRTI, TMC278, Presented at AIDS 2008: Phase IIb study examines efficacy and safety of once-daily TMC278 in treatment-naive adults with HIV-1
PRNewswire - August 5, 2008
MEXICO CITY, Aug. 5 /PRNewswire/ -- New phase IIb data from Tibotec Pharmaceuticals Ltd. provides additional information on the safety and efficacy of TMC278, the company s once-daily, investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), as part of HIV combination therapy in treatment-naive adults. T


TMC278 Demonstrates Long-Term Efficacy and Tolerability in Treatment-Naïve Adults With HIV: Ninety-Six-Week Data on Tibotec Investigational NNRTI Presented at AIDS 2008
PRNewswire - August 5, 2008
MEXICO CITY, Mexico, August 5/PRNewswire/ -- New phase IIb data from Tibotec Pharmaceuticals Ltd. show that TMC278, the company s once-daily, investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), provides long-term efficacy and tolerability in treatment-naïve adults with HIV. Ninety-six-week study res


New Report Finds Investment in AIDS Vaccine and Microbicide R&D Continues to Increase Incrementally in 2007
PRNewswire - August 5, 2008
-- Calls for Sustained Funding to Maintain HIV Prevention Research Efforts MEXICO CITY, Aug. 5 /PRNewswire-USNewswire/ -- A new report released today shows that funding for biomedical HIV prevention research and development (R&D), including AIDS vaccines and microbicides, increased dramatically between 2000 and 200


Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
PRNewswire - August 5, 2008
-- 88% of patients achieve undetectable HCV RNA levels following 4 weeks of treatment with R7128 1000mg BID with Pegasys(R) plus Copegus(R) -- Safety and tolerability comparable to placebo administered with Pegasys plus Copegus PRINCETON, N.J., Aug. 5 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (NASDAQ:VRUS) announces t


Monogram Biosciences Launches First Resistance Assay for HIV Integrase Inhibitors: PhenoSense(R) Integrase Now Enables Clinicians to Monitor Activity of New Class of Potent Antiretroviral Drugs
PRNewswire - August 4, 2008
SOUTH SAN FRANCISCO, Calif., Aug. 4 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. (Nasdaq: MGRM) today announced the launch of its PhenoSense(R) Integrase assay, built on Monogram s proprietary technology platform, PhenoSense(R). The assay directly measures the susceptibility of HIV to a new and potent class of


Latest CDC Report on HIV Incidence Grossly Excludes Hispanics in 2006, the Fastest Growing Ethnic Population in the United States and its Territories
PRNewswire - August 4, 2008
MEXICO CITY, Aug. 4 /PRNewswire-USNewswire/ -- In an apparent reversal of CDC s January 2008 decision to revise the number of new Hispanic HIV/AIDS diagnoses based on the inclusion of Puerto Ricans as Hispanics, the latest CDC report released in August 2008, entitled Estimation of HIV Incidence in the Unit


Landmark Global Survey of People Living with HIV and AIDS Shows Concerning Results that Side Effects are Leading Cause for U.S. Respondents to Discontinue or Switch Treatment Regimens
PRNewswire - August 4, 2008
-- Despite 25 Years of Pandemic, U.S. Respondents Are Still Concerned about Stigma and Discrimination MEXICO CITY, Aug. 4 /PRNewswire/ -- Results from the groundbreaking AIDS Treatment for Life International Survey (ATLIS), which polled nearly 3,000 HIV-positive patients from 18 countries, show that a concerning number


JAMA Commentary Opposes Criminal Punishment for HIV Exposure/Transmission: Authors to Discuss Issue at International AIDS Conference, August 3-8
PRNewswire - August 4, 2008
CHICAGO, Aug. 4 /PRNewswire/ -- Criminal punishment for exposure to or transmission of HIV does nothing to reduce the spread of the virus. Instead, it increases stigma and drives people away from accessing care, while disproportionately burdening women and other vulnerable groups who are unable to disclose their HIV st


As AIDS Conference Opens, amfAR Releases Report Exposing Global Failure to Address HIV Among MSM
PRNewswire - August 4, 2008
-- Ban Ki-moon, Margaret Chan, and presidents from Africa and Latin America call for governments to target epidemic among men who have sex with men MEXICO CITY, Aug. 4 /PRNewswire-USNewswire/ -- A day after leaders from the United Nations and the World Health Organization called attention to the need to combat AIDS amo


AIDS Action Committee Applauds Legislature for Taking Action to Protect Patient Privacy Within New Electronic Medical Records System
PRNewswire - August 4, 2008
-- Measures on privacy and data security set foundation for future systems BOSTON, Aug. 4 /PRNewswire-USNewswire/ -- AIDS Action Committee of Massachusetts, Inc. (AAC) commends state lawmakers for passing legislation that includes privacy and data security protections within a statewide electronic medical records syste


New AVAC Report on Pre-Exposure Prophylaxis Calls for Immediate Planning to Anticipate Study Results of Potential New HIV Prevention Option
PRNewswire - August 3, 2008
-- Now is the time to anticipate and plan for various study outcomes MEXICO CITY, Aug. 3 /PRNewswire/ -- The AIDS Vaccine Advocacy Coalition (AVAC) today released a new report, Anticipating the Results of PrEP Trials, calling for increased action from governments, global health institutions, donors, researchers, and ad


Growing Epidemic in Gay and Bisexual Men in the United States Heightens the Call for a National AIDS Strategy Bridging Race and Sexuality
PRNewswire - August 3, 2008
MEXICO CITY, Aug. 3 /PRNewswire-USNewswire/ -- In the wake of disturbing news about higher HIV rates in the United States , people living with HIV and allies are calling for a national AIDS strategy that confronts the homophobia, violence and bias at the heart of the U.S. epidemic. The Centers for Disease Control and P


Estimate of Annual HIV Incidence Increases to 56,300: Release Of New Estimate Shows Need For A National Aids Strategy
PRNewswire - August 2, 2008
WASHINGTON, Aug. 2 /PRNewswire-USNewswire/ -- The federal Centers for Disease Control and Prevention s (CDC) long anticipated revised estimate of annual new cases of HIV infections was revealed today in a paper published in the Aug. 6, 2008 issue of the Journal of the American Medical Association (JAMA). The revise


New HIV Infection Figures from CDC Underscore Need for National AIDS Strategy for the U.S.
PRNewswire - August 2, 2008
-- Announcement of increased new infections in 2006 follows nearly two-year delay in releasing data WASHINGTON, Aug. 2 /PRNewswire-USNewswire/ -- The new HIV infection figures by the Centers for Disease Control and Prevention (CDC) increase the estimate of new HIV infections in 2006 from 40,000 to 56,300. Though the ag


Estimate of Annual HIV Incidence Increases Significantly; New Estimate Will Show Need For a National AIDS Strategy
PRNewswire - August 1, 2008
WASHINGTON, Aug. 1 /PRNewswire-USNewswire/ -- The federal Centers for Disease Control and Prevention s (CDC) long anticipated revised estimate of annual new cases of HIV infections will be revealed on Aug. 3 in a paper published in the Journal of the American Medical Association (JAMA). The revised estimated number of


Kay Warren Reveals Solution to Gender-Based Violence: The Worldwide Church, Which Offers Hope to the World;
PRNewswire - August 1, 2008
-- Warren Presents Church-based Strategy of Hope and Healing in Plenary, Workshop at Ecumenical Alliance Conference in Mexico City MEXICO CITY, Aug. 1 /PRNewswire/ -- Kay Warren, international AIDS advocate, author and director of the HIV/AIDS Initiative at Saddleback Church in Lake Forest, Calif., today addressed the


Ford Foundation Says Rights and Opportunity Are Critical for People Living Longer with HIV: Advanced Treatment is Extending Lives, but Social Progress is Needed for People to Live Full Lives with the Disease
PRNewswire - August 1, 2008
MEXICO CITY, Aug. 1 /PRNewswire-USNewswire/ -- As millions of people across the globe begin accessing treatment and care for HIV/AIDS, the Ford Foundation today said that creating a world where people with HIV/AIDS can lead full lives with dignity, purpose and access to opportunity is a critical priority in the global


International AIDS Conference an 'Expensive Talking Shop' Unless More Done for Children: World Vision calls for action to protect, care for children impacted by HIV and AIDS
PRNewswire - August 1, 2008
-- Mexico City event a chance to spur help for millions of orphans and vulnerable children MEXICO CITY, Aug. 1 /PRNewswire/ -- A leading humanitarian agency has today warned that the world s biggest conference on HIV and AIDS will miss the mark unless attendees come away making firm commitments to end mother-to-child t


Ann Lion Coleman Joins Abt Associates to Direct USAID Health Systems 20/20 Project
PRNewswire - July 31, 2008
CAMBRIDGE, Mass., July 31 /PRNewswire/ -- HIV/AIDS and health systems expert Ann Lion Coleman will join Abt Associates as Director for the Health Systems 20/20 project in August 2008. Health Systems 20/20 is the USAID Bureau of Global Health s flagship project working to strengthen health systems by using an integrated


African American-Owned Condom Company Fears the Widening AIDS Epidemic
PRNewswire - July 31, 2008
WEST MEMPHIS, Ark., July 31 /PRNewswire/ -- When Kirk Manuel speaks, you hear anguish in his voice. You hear the heartbreak of a man who has see one too many members of his community impacted by HIV and AIDS. When Kirk Manuel speaks, you hear courage in his voice, too. You hear a man who believes in his product, Head S


Higher Number of HIV Infections Must Translate Into Leadership & Action by U.S. Government
PRNewswire - July 31, 2008
-- Additional Funding for HIV Prevention & Sound Public Policies Needed WASHINGTON, July 31 /PRNewswire-USNewswire/ -- As the world s attention turns to the global HIV/AIDS epidemic with the convening of the International AIDS Conference in Mexico City, the U.S. Centers for Disease Control and Prevention (CDC) is a


Catholics at International AIDS Conference XVII Tell Pope: End Ban on Condoms
PRNewswire - July 31, 2008
MEXICO CITY, July 31 /PRNewswire-USNewswire/ -- As thousands gather in Mexico City for the 17th International AIDS Conference August 3-8, 2008, Catholics for Choice and its Latin American sister organizations, Catolicas por el Derecho a Decidir, will be highlighting Catholic opposition to the Vatican s ban on condoms u


The Latino Commission on AIDS Releases Report on the State of HIV/AIDS in Latino/Hispanic Communities in the United States on the Eve of the International AIDS Conference in Mexico City
PRNewswire - July 30, 2008
-- A National Delegation of the Commission will dialogue with leaders at the Conference to share and learn about successful strategies in response to the HIV/AIDS pandemic NEW YORK, July 30 /PRNewswire-USNewswire/ -- Hispanics in the United States are the second most affected community, it is estimated that more than 2


Bill & Melinda Gates Congratulate President Bush on Signing of AIDS, TB, and Malaria Funding Reauthorization Bill
PRNewswire - July 30, 2008
SEATTLE, July 30 /PRNewswire-USNewswire/ -- President George W. Bush today signed legislation that reauthorizes the President s Emergency Plan for AIDS Relief (PEPFAR) and other global health funding. In response, Bill and Melinda Gates, co-chairs of the Bill & Melinda Gates Foundation, made the following statement


National Medical Association Installs 109th President at Atlanta Convention: New NMA President to Address Cancer and Mental Health Disparities
PRNewswire - July 30, 2008
ATLANTA, July 30 /PRNewswire-USNewswire/ -- Delivering her inaugural address as the 109th president of the National Medical Association (NMA), Carolyn Barley Britton, M.D., M.S., shared her plans to focus on cancer and mental health disparities during her administration. The NMA is the nation s premier organization for


AIDS Action Applauds Introduction of a New Bill Allowing Federal Funds to Support Syringe Exchange Programs
PRNewswire - July 30, 2008
WASHINGTON, July 30 /PRNewswire-USNewswire/ -- On Wednesday, July 30th, Representative Jose Serrano (D-NY) introduced the Community AIDS and Hepatitis Prevention Act, a bill which, if passed, will remove all legal barriers to States and local jurisdictions to spend federal funding that they receive for prevention of di


Ramsell Pharmacy Solutions and Mirixa Announce National Pharmacy Initiative to Serve People Living with HIV/AIDS
PRNewswire - July 30, 2008
-- Innovative HIV/AIDS Program for Public Health Insured Patients to be Delivered by Community Pharmacists using Mirixa technology RESTON, Va. and OAKLAND, Calif., July 30 /PRNewswire/ -- Mirixa Corporation and Ramsell Pharmacy Solutions jointly announced today the launch of a pharmacist-delivered medication therapy ma


Bush to Sign AIDS Bill Today, but Funding Still Missing
PRNewswire - July 30, 2008
WASHINGTON, July 30 /PRNewswire-USNewswire/ -- Today President Bush will sign into law a major new piece of legislation on global AIDS, tuberculosis and malaria, but Congress is not providing the money to implement it for fiscal year 2009. We deeply appreciate the hard work of everyone involved, in the Congress and the


New 'From-the-Ground' Report Reformulates Simplistic Argument About HIV/ AIDS and Health Care Systems in a Fundamental Way
PRNewswire - July 30, 2008
-- Dr. Jim Kim of Harvard School of Public Health joins International Treatment Preparedness Coalition to release new report and call for broad, systematic approach to HIV/AIDS and health care scale up NEW YORK and HARARE, Zimbabwe and BOSTON and SAO PAULO, Brazil , July 29 /PRNewswire-USNewswire/ -- T


ImQuest Receives Two Year Phase 2 SBIR Grant to Develop Pyrimidinedione Product as an Anti-HIV Topical Microbicide
PRNewswire - July 29, 2008
FREDERICK, Md., July 29 /PRNewswire/ -- ImQuest BioSciences announced today the successful acquisition of funding from the National Institute of Allergy and Infectious Disease (NIAID/NIH) to support the development of pyrimidinedione inhibitors as topical microbicides to prevent the sexual transmission of HIV. The two


Three Rs and HIV/AIDS Mark New Haiti Literacy Plan
PRNewswire - July 29, 2008
WASHINGTON, July 29/PRNewswire-USNewswire/ -- Increasing literacy and curbing HIV/AIDS is the centerpiece of the U.S. Agency for International Development s (USAID) new three-year effort designed to stabilize parts of Haiti plagued by community unrest. The Haiti Basic Education Project -- a $19 million investment -- wi


Idenix Pharmaceuticals Advances HCV Discovery Program to Clinic
PRNewswire - July 29, 2008
-- Initiates IDX184 Phase I Clinical Study and Advances HCV Protease Inhibitor and Non-Nucleoside Polymerase Inhibitor Clinical Candidates into IND-Enabling Preclinical Studies ~ CAMBRIDGE, Mass., July 29 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX), a biopharmaceutical company engaged in the di


Abbott Fund and the Government of Tanzania Celebrate Milestone in Strengthening Nation's Health Care System
PRNewswire - July 28, 2008
Partnership Will Modernize All Regional Hospital Laboratories to Improve Access to Care Across the Country DAR ES SALAAM, Tanzania , July 28 /PRNewswire-FirstCall/ -- At a ceremony today, the Ministry of Health and Social Welfare, United Republic of Tanzania, and Abbott Fund commemorated the latest step in a nationwide


Ardea to Present Data on Lead HIV Candidate, RDEA806, at ICAAC/IDSA Joint Meeting
PRNewswire - July 28, 2008
SAN DIEGO, July 28 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (NASDAQ:RDEA) today announced that data will be presented on RDEA806, the Company s novel investigational non-nucleoside reverse transcriptase inhibitor (NNRTI) for patients with human immunodeficiency virus (HIV) at the 48th Annual ICAAC/IDSA 46th An


AIDS Vaccines: Where Do We Go From Here?
PRNewswire - July 28, 2008
The International AIDS Vaccine Initiative (IAVI) and Key Thought Leaders Explore Critical Next Steps for AIDS Vaccine Research at the 17th International AIDS Conference in Mexico City NEW YORK, July 28 /PRNewswire-USNewswire/ -- The following was released today by the International AIDS Vaccine Initiative: WHAT: To


Media Advisory (Telephone Press Conference): Is Donor AIDS Money Strengthening Health Systems? New Study Finds Missed Opportunities
PRNewswire - July 28, 2008
The Center for Global Development will hold a telephone press conference on July 29, 2008 to introduce new research ahead of the official launch event at the International AIDS Conference in Mexico City. The report, Seizing the Opportunity on AIDS and Health Systems, finds that billions of dollars in donor money being


HIV Prevention Expert Dr. Timothy Mastro Speaks on Future of Pre-Exposure Prophylaxis at International AIDS Conference
PRNewswire - July 27, 2008
RESEARCH TRIANGLE PARK, N.C., July 27 /PRNewswire/ -- Timothy Mastro, MD, FACP, DTM&H, who joins Family Health International (FHI) on August 1st as Senior Director of Research, will share information on promising research into pre-exposure prophylaxis (PrEP) for HIV prevention at the International AIDS Conference i


Congress Sends Global HIV/AIDS Legislation to the President
PRNewswire - July 24, 2008
WASHINGTON, July 24 /PRNewswire-USNewswire/ - The landmark U.S. effort to fight HIV/AIDS around the world will be expanded and extended by five years thanks to legislation that Congress passed today. By a vote of 303 to 115, the House approved Senate amendments to the Tom Lantos and Henry J. Hyde United Stat


Pelosi Statement on House Passage of Global AIDS Legislation
PRNewswire - July 24, 2008
WASHINGTON, July 24 /PRNewswire-USNewswire/ -- Speaker Nancy Pelosi released the following statement this evening in support of the Tom Lantos and Henry J. Hyde Global Leadership Against HIV/Aids, Tuberculosis, and Malaria Reauthorization Act of 2008. The bill, which passed the Senate last week, passed the House this e


Webcast Alert: JAMA Media Briefing on HIV/AIDS
PRNewswire - July 24, 2008
MEXICO CITY, July 24 /PRNewswire/ -- New research from the Journal of the American Medical Association (JAMA) theme issue on HIV/AIDS will be released to the media, coinciding with the International AIDS Conference. Four of the world s top HIV/AIDS researchers will present their findings on new therapies, treatment gui


Studies Assessed by European Health Authority Conclude That Impurity in Roche's Viracept(R) (nelfinavir mesylate) Did Not Increase Patient's Risk of Cancer
PRNewswire - July 24, 2008
Basel, Switzerland (PRNewswire) - The European Committee for Human Medicinal Products (CHMP) has confirmed that the presence of an impurity called ethyl methanesulfonate (EMS) in Roche s Viracept (nelfinavir mesylate) did not increase patients risk of developing cancer.


Latino Commission on AIDS Welcomes Miss Universe 2008 Dayana Mendoza as its Newest 'Madrina' in the Fight Against AIDS
PRNewswire - July 24, 2008
NEW YORK, July 24 /PRNewswire-USNewswire/ -- Miss Universe 2008 Dayana Mendoza is the newest Madrina of the Latino Commission on AIDS, announced Dennis deLeon, President of the Latino Commission on AIDS. Dayana Mendoza visited the offices of the Commission in New York on July 23rd and received a comprehensive briefing


GeoVax Partners with Vivalis for Use of Its Revolutionary EBx(R) Technology to Manufacture Its MVA HIV/AIDS Vaccine
PRNewswire - July 22, 2008
-- Partnership creates worldwide strategic collaboration between Vivalis and GeoVax ATLANTA and NANTES, France , July 22 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Viru


Cavidi Calls for Greater Access to HIV Monitoring at AIDS 2008 Conference in Mexico
PRNewswire - July 22, 2008
UPPSALA, Sweden , July 22 /PRNewswire/ -- Cavidi is attending the XVII International AIDS Conference in Mexico City, August 3-8, 2008 to spread its message of the need for greater access to HIV viral load monitoring. Lately the supply of HIV medicines (ARVs) to the developing world has been increasing. This is a wonder


Presumed Presidential Nominees McCain and Obama to Make First Joint Campaign Appearance on August 16 at Saddleback Church
PRNewswire - July 21, 2008
Pastor Rick Warren to Host Saddleback Civil Forum on Leadership and Compassion and Question Candidates on Faith and the Common Good LAKE FOREST, Calif., July 21 /PRNewswire-USNewswire/ -- Sens. John McCain and Barack Obama, respective presumed Republican and Democratic presidential nominees, will end the primary season


VIRxSYS to Host a Web Conference to Announce Clinical Trial Update: Summary of data from five 2008 conferences
PRNewswire - July 21, 2008
GAITHERSBURG, Md., July 21 /PRNewswire/ -- VIRxSYS Corporation, a privately held company developing gene therapies for HIV and genetic diseases, will present an update on the VRX496 Phase I and Phase II clinical trials for the media and members of the advocacy community. VRX496 is an investigational gene therapy for th


Catholics Asked to Tell Their Bishops to End Ban on Contraception
PRNewswire - July 21, 2008
-- July 25th Marks 40th Anniversary of Vaticans Devastating Decision WASHINGTON, July 21 /PRNewswire-USNewswire/ -- Forty years ago, a decision was announced that has had a catastrophic impact on the poor and powerless around the world. On July 25, 1968, Pope Paul VI slammed the door on the hopes of the vast majority o


Tibotec Conducts Two Pivotal Phase III Clinical Trials Studying TMC278 in Treatment-Naive Adults with HIV
PRNewswire - July 17, 2008
-- Once-daily TMC278, the third anti-HIV compound to be developed in Tibotec virology portfolio YARDLEY, Pa., July 17 /PRNewswire/ -- Tibotec Pharmaceuticals Ltd. announced today that two major phase III efficacy trials examining TMC278, its investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), in tre


Senate Committee Approves $1.4 Million for Development of National AIDS Strategy
PRNewswire - July 17, 2008
WASHINGTON, July 17 /PRNewswire-USNewswire/ -- Last week, the Senate Appropriations Committee passed the Financial Services appropriations bill for the coming fiscal year that includes $1.4 million to the White House Office of National AIDS Policy for the development of a National AIDS Strategy. The House of Representa


Ardea to Present Data on Lead HIV Candidate, RDEA806, at XVII International AIDS Conference
PRNewswire - July 17, 2008
SAN DIEGO, July 17 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA - News) today announced that Dr. Graeme Moyle, Director of HIV Research, Chelsea and Westminster Hospital, will present results from the Phase 2a proof-of-concept monotherapy study of RDEA806, during an oral presentation at a late breake


Diplomat's 2008 Patient Satisfaction Survey Sets the Bar for Specialty Pharmacy Industry
PRNewswire - July 17, 2008
SWARTZ CREEK, Mich., July 17, 2008 /PRNewswire via COMTEX/ -- Diplomat Specialty Pharmacy, the nation s largest independent specialty pharmacy, released today results of their Spring 2008 Patient Satisfaction Survey. The national survey was mailed to 1500 patients, randomly selected from its own database of approximate


Senate Passes Landmark AIDS, TB and Malaria Bill, Says Global AIDS Alliance
PRNewswire - July 16, 2008
WASHINGTON, July 16 /PRNewswire-USNewswire/ -- Today the U.S. Senate passed a crucial bill, backed by President Bush, that reauthorizes the U.S. program on global HIV/AIDS while also authorizing much greater funding for programs to address tuberculosis and malaria. The bill is a tremendous achievement, and I commend Se


AIDS Action Commends Senate Passage of PEPFAR Reauthorization
PRNewswire - July 16, 2008
WASHINGTON, July 16 /PRNewswire-USNewswire/ -- AIDS Action applauds the Senate for overwhelming, bipartisan passage of the Lantos/Hyde U.S. Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act (S 2731), which reauthorizes the President s Emergency Plan For AIDS Relief (PEPFAR). The organiza


Online Coverage of International AIDS Conference Includes Daily Webcasts, Podcasts and Interviews
PRNewswire - July 16, 2008
-- INTERNATIONAL AIDS SOCIETY AND KAISER FAMILY FOUNDATION PARTNER TO OFFER DAILY, COMPREHENSIVE COVERAGE OF CONFERENCE FOR FREE MENLO PARK, Calif., and GENEVA, July 16 /PRNewswire-USNewswire/ -- The International AIDS Society (IAS